{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:34:43Z","timestamp":1779917683352,"version":"3.53.1"},"reference-count":234,"publisher":"American Institute of Mathematical Sciences (AIMS)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MBE"],"published-print":{"date-parts":[[2026]]},"DOI":"10.3934\/mbe.2026038","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T01:39:22Z","timestamp":1772674762000},"page":"987-1049","source":"Crossref","is-referenced-by-count":1,"title":["Immune dysregulation in COVID-19: Mathematical modeling of the within-host dynamics"],"prefix":"10.3934","volume":"23","author":[{"given":"Keopagnapech","family":"Ngoun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Engineering, Elon University, 100 Campus Drive, Elon, NC, 27244, USA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesh","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwayeon","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Mathematics and Statistics, Elon University, 100 Campus Drive, Elon, NC, 27244, USA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Center for Gastrointestinal Biology and Disease, University of North Carolina at Chapel Hill, 130 Mason Farm Road, Bioinformatics Building CB# 7080, Chapel Hill, NC, 27599, USA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2321","reference":[{"key":"key-10.3934\/mbe.2026038-1","doi-asserted-by":"publisher","unstructured":"B. Zeng, L. Gao, Q. Zhou, K. Yu, F. Sun, Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: A systematic review and meta-analysis, BMC Med.<\/i>, 20<\/b> (2022), 200. https:\/\/doi.org\/10.1186\/s12916-022-02397-y","DOI":"10.1186\/s12916-022-02397-y"},{"key":"key-10.3934\/mbe.2026038-2","doi-asserted-by":"publisher","unstructured":"D. L. Farber, Tissues, not blood, are where immune cells function, Nature<\/i>, 593<\/b> (2021), 506\u2013509. https:\/\/doi.org\/10.1038\/d41586-021-01396-y","DOI":"10.1038\/d41586-021-01396-y"},{"key":"key-10.3934\/mbe.2026038-3","doi-asserted-by":"publisher","unstructured":"P. A. Szabo, P. Dogra, J. I. Gray, S. B. Wells, T. J. Connors, S. P. Weisberg, et al., Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19, Immunity<\/i>, 54<\/b> (2021), 797\u2013814. https:\/\/doi.org\/10.1016\/j.immuni.2021.03.005","DOI":"10.1016\/j.immuni.2021.03.005"},{"key":"key-10.3934\/mbe.2026038-4","doi-asserted-by":"publisher","unstructured":"R. S. Thwaites, A. Uruchurtu, M. K. Siggins, F. Liew, C. D. Russell, S. C. Moore, et al., Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19, Sci. Immunol.<\/i>, 6<\/b> (2021), eabg9873. https:\/\/doi.org\/10.1126\/sciimmunol.abg9873","DOI":"10.1126\/sciimmunol.abg9873"},{"key":"key-10.3934\/mbe.2026038-5","doi-asserted-by":"publisher","unstructured":"C. Liu, A. J. Martins, W. W. Lau, N. Rachmaninoff, J. Chen, L. Imberti, et al., Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19, Cell<\/i>, 184<\/b> (2021), 1836\u20131857. https:\/\/doi.org\/10.1016\/j.cell.2021.02.018","DOI":"10.1016\/j.cell.2021.02.018"},{"key":"key-10.3934\/mbe.2026038-6","doi-asserted-by":"publisher","unstructured":"B. Hu, S. Huang, L. Yin, The cytokine storm and COVID-19, J. Med. Virol.<\/i>, 93<\/b> (2021), 250\u2013256. https:\/\/doi.org\/10.1002\/jmv.26232","DOI":"10.1002\/jmv.26232"},{"key":"key-10.3934\/mbe.2026038-7","doi-asserted-by":"publisher","unstructured":"C. Huang, Y. Wang, X. Li, L. Ren, J. Zhao, Y. Hu, et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, The Lancet<\/i>, 395<\/b> (2020), 497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"key-10.3934\/mbe.2026038-8","doi-asserted-by":"publisher","unstructured":"P. Mehta, D. F. McAuley, M. Brown, E. Sanchez, R. S. Tattersall, J. J. Manson, COVID-19: Consider cytokine storm syndromes and immunosuppression, The Lancet<\/i>, 395<\/b> (2020), 1033\u20131034. https:\/\/doi.org\/10.1016\/S0140-6736(20)30628-0","DOI":"10.1016\/S0140-6736(20)30628-0"},{"key":"key-10.3934\/mbe.2026038-9","doi-asserted-by":"publisher","unstructured":"R. J. Jose, A. Manuel, COVID-19 cytokine storm: The interplay between inflammation and coagulation, Lancet Respir. Med.<\/i>, 8<\/b> (2020), e46\u2013e47. https:\/\/doi.org\/10.1016\/S2213-2600(20)30216-2","DOI":"10.1016\/S2213-2600(20)30216-2"},{"key":"key-10.3934\/mbe.2026038-10","doi-asserted-by":"publisher","unstructured":"A. Bahsoun, Y. Fakih, R. Zareef, F. Bitar, M. Arabi, Corticosteroids in COVID-19: Pros and cons, Front. Med.<\/i>, 10<\/b> (2023), 1202504. https:\/\/doi.org\/10.3389\/fmed.2023.1202504","DOI":"10.3389\/fmed.2023.1202504"},{"key":"key-10.3934\/mbe.2026038-11","doi-asserted-by":"publisher","unstructured":"P. Du, J. Geng, F. Wang, X. Chen, Z. Huang, Y. Wang, Role of IL-6 inhibitor in treatment of COVID-19-related cytokine release syndrome, Int. J. Med. Sci.<\/i>, 18<\/b> (2021), 1356. https:\/\/doi.org\/10.7150\/ijms.53564","DOI":"10.7150\/ijms.53564"},{"key":"key-10.3934\/mbe.2026038-12","doi-asserted-by":"publisher","unstructured":"R. Najjar-Debbiny, N. Gronich, G. Weber, J. Khoury, M. Amar, N. Stein, et al., Effectiveness of paxlovid in reducing severe coronavirus disease 2019 and mortality in high-risk patients, Clin. Infect. Dis.<\/i>, 76<\/b> (2023), e342\u2013e349. https:\/\/doi.org\/10.1093\/cid\/ciac443","DOI":"10.1093\/cid\/ciac443"},{"key":"key-10.3934\/mbe.2026038-13","doi-asserted-by":"publisher","unstructured":"Z. Zhou, D. Li, Z. Zhao, S. Shi, J. Wu, J. Li, et al., Dynamical modelling of viral infection and cooperative immune protection in COVID-19 patients, PLOS Comput. Biol.<\/i>, 19<\/b> (2023), e1011383. https:\/\/doi.org\/10.1371\/journal.pcbi.1011383","DOI":"10.1371\/journal.pcbi.1011383"},{"key":"key-10.3934\/mbe.2026038-14","doi-asserted-by":"publisher","unstructured":"A. L. Jenner, R. A. Aogo, S. Alfonso, V. Crowe, X. Deng, A. P. Smith, et al., COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes, PLOS Pathog.<\/i>, 17<\/b> (2021), e1009753. https:\/\/doi.org\/10.1371\/journal.ppat.1009753","DOI":"10.1371\/journal.ppat.1009753"},{"key":"key-10.3934\/mbe.2026038-15","doi-asserted-by":"publisher","unstructured":"L. Fan, Z. Qiu, Q. Deng, T. Guo, L. Rong, Modeling SARS-CoV-2 infection dynamics: Insights into viral clearance and immune synergy, Bull. Math. Biol.<\/i>, 87<\/b> (2025), 67. https:\/\/doi.org\/10.1007\/s11538-025-01442-0","DOI":"10.1007\/s11538-025-01442-0"},{"key":"key-10.3934\/mbe.2026038-16","doi-asserted-by":"publisher","unstructured":"A. Goyal, E. F. Cardozo-Ojeda, J. T. Schiffer, Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response, Sci. Adv.<\/i>, 6<\/b> (2020), eabc7112. https:\/\/doi.org\/10.1126\/sciadv.abc7112","DOI":"10.1126\/sciadv.abc7112"},{"key":"key-10.3934\/mbe.2026038-17","doi-asserted-by":"publisher","unstructured":"M. Sadria, A. T. Layton, Modeling within-host SARS-CoV-2 infection dynamics and potential treatments, Viruses<\/i>, 13<\/b> (2021), 1141. https:\/\/doi.org\/10.3390\/v13061141","DOI":"10.3390\/v13061141"},{"key":"key-10.3934\/mbe.2026038-18","doi-asserted-by":"publisher","unstructured":"A. Goyal, E. R. Duke, E. F. Cardozo-Ojeda, J. T. Schiffer, Modeling explains prolonged SARS-CoV-2 nasal shedding relative to lung shedding in remdesivir-treated rhesus macaques, iScience<\/i>, 25<\/b> (2022), 104448. https:\/\/doi.org\/10.1016\/j.isci.2022.104448","DOI":"10.1016\/j.isci.2022.104448"},{"key":"key-10.3934\/mbe.2026038-19","doi-asserted-by":"publisher","unstructured":"B. Chatterjee, H. S. Sandhu, N. M. Dixit, Modeling recapitulates the heterogeneous outcomes of SARS-CoV-2 infection and quantifies the differences in the innate immune and CD8 T-cell responses between patients experiencing mild and severe symptoms, PLOS Pathog.<\/i>, 18<\/b> (2022), e1010630. https:\/\/doi.org\/10.1371\/journal.ppat.1010630","DOI":"10.1371\/journal.ppat.1010630"},{"key":"key-10.3934\/mbe.2026038-20","doi-asserted-by":"publisher","unstructured":"N. Heitzman-Breen, S. M. Ciupe, Modeling within-host and aerosol dynamics of SARS-CoV-2: The relationship with infectiousness, PLOS Comput. Biol.<\/i>, 18<\/b> (2022), e1009997. https:\/\/doi.org\/10.1371\/journal.pcbi.1009997","DOI":"10.1371\/journal.pcbi.1009997"},{"key":"key-10.3934\/mbe.2026038-21","doi-asserted-by":"publisher","unstructured":"T. Song, Y. Wang, X. Gu, S. Qiao, Modeling the within-host dynamics of SARS-CoV-2 infection based on antiviral treatment, Mathematics<\/i>, 11<\/b> (2023), 3485. https:\/\/doi.org\/10.3390\/math11163485","DOI":"10.3390\/math11163485"},{"key":"key-10.3934\/mbe.2026038-22","doi-asserted-by":"publisher","unstructured":"I. Al-Darabsah, K. L. Liao, S. Portet, A simple in-host model for COVID-19 with treatments: Model prediction and calibration, J. Math. Biol.<\/i>, 86<\/b> (2023), 20. https:\/\/doi.org\/10.1007\/s00285-022-01849-6","DOI":"10.1007\/s00285-022-01849-6"},{"key":"key-10.3934\/mbe.2026038-23","doi-asserted-by":"publisher","unstructured":"C. Byrne, J. T. Schiffer, Ensemble modeling of SARS-CoV-2 immune dynamics in immunologically na\u00efve rhesus macaques predicts that potent, early innate immune responses drive viral elimination, Front. Immunol.<\/i>, 15<\/b> (2024), 1426016. https:\/\/doi.org\/10.3389\/fimmu.2024.1426016","DOI":"10.3389\/fimmu.2024.1426016"},{"key":"key-10.3934\/mbe.2026038-24","doi-asserted-by":"publisher","unstructured":"L. Schuh, P. V. Markov, V. M. Veliov, N. I. Stilianakis, A mathematical model for the within-host (re)infection dynamics of SARS-CoV-2, Math. Biosci.<\/i>, 371<\/b> (2024), 109178. https:\/\/doi.org\/10.1016\/j.mbs.2024.109178","DOI":"10.1016\/j.mbs.2024.109178"},{"key":"key-10.3934\/mbe.2026038-25","doi-asserted-by":"publisher","unstructured":"R. Ke, C. Zitzmann, D. D. Ho, R. M. Ribeiro, A. S. Perelson, In vivo kinetics of SARS-CoV-2 infection and its relationship with a person's infectiousness, Proc. Natl. Acad. Sci.<\/i>, 118<\/b> (2021), e2111477118. https:\/\/doi.org\/10.1073\/pnas.2111477118","DOI":"10.1073\/pnas.2111477118"},{"key":"key-10.3934\/mbe.2026038-26","doi-asserted-by":"publisher","unstructured":"R. Ke, P. P. Martinez, R. L. Smith, L. L. Gibson, A. Mirza, M. Conte, et al., Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness, Nat. Microbiol.<\/i>, 7<\/b> (2022), 640\u2013652. https:\/\/doi.org\/10.1038\/s41564-022-01105-z","DOI":"10.1038\/s41564-022-01105-z"},{"key":"key-10.3934\/mbe.2026038-27","doi-asserted-by":"publisher","unstructured":"K. Owens, S. Esmaeili, J. T. Schiffer, Heterogeneous SARS-CoV-2 kinetics due to variable timing and intensity of immune responses, JCI Insights<\/i>, 9<\/b> (2024), e176286. https:\/\/doi.org\/10.1172\/jci.insight.176286","DOI":"10.1172\/jci.insight.176286"},{"key":"key-10.3934\/mbe.2026038-28","doi-asserted-by":"publisher","unstructured":"I. Ghosh, Within host dynamics of SARS-CoV-2 in humans: Modeling immune responses and antiviral treatments, SN Comput. Sci.<\/i>, 2<\/b> (2021), 482. https:\/\/doi.org\/10.1007\/s42979-021-00919-8","DOI":"10.1007\/s42979-021-00919-8"},{"key":"key-10.3934\/mbe.2026038-29","doi-asserted-by":"publisher","unstructured":"J. Li, J. Wu, J. Zhang, L. Tang, H. Mei, Y. Hu, et al., A multicompartment mathematical model based on host immunity for dissecting COVID-19 heterogeneity, Heliyon<\/i>, 8<\/b> (2022), e09488. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e09488","DOI":"10.1016\/j.heliyon.2022.e09488"},{"key":"key-10.3934\/mbe.2026038-30","doi-asserted-by":"publisher","unstructured":"A. Mazzoni, L. Salvati, L. Maggi, M. Capone, A. Vanni, M. Spinicci, et al., Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent, J. Clin. Invest.<\/i>, 130<\/b> (2020), 4694\u20134703. https:\/\/doi.org\/10.1172\/JCI138554","DOI":"10.1172\/JCI138554"},{"key":"key-10.3934\/mbe.2026038-31","doi-asserted-by":"publisher","unstructured":"G. Leem, S. Cheon, H. Lee, S. J. Choi, S. Jeong, E. S. Kim, et al., Abnormality in the NK-cell population is prolonged in severe COVID-19 patients, J. Allergy Clin. Immunol.<\/i>, 148<\/b> (2021), 996\u20131006. https:\/\/doi.org\/10.1016\/j.jaci.2021.07.022","DOI":"10.1016\/j.jaci.2021.07.022"},{"key":"key-10.3934\/mbe.2026038-32","doi-asserted-by":"publisher","unstructured":"J. Barros-Martins, R. F\u00f6rster, B. Bo\u0161njak, NK cell dysfunction in severe COVID-19: TGF-$\\beta$-induced downregulation of integrin beta-2 restricts NK cell cytotoxicity, Signal Transduction Targeted Ther.<\/i>, 7<\/b> (2022), 32. https:\/\/doi.org\/10.1038\/s41392-022-00892-5","DOI":"10.1038\/s41392-022-00892-5"},{"key":"key-10.3934\/mbe.2026038-33","doi-asserted-by":"publisher","unstructured":"J. Bi, NK cell dysfunction in patients with COVID-19, Cell. Mol. Immunol.<\/i>, 19<\/b> (2022), 127\u2013129. https:\/\/doi.org\/10.1038\/s41423-021-00825-2","DOI":"10.1038\/s41423-021-00825-2"},{"key":"key-10.3934\/mbe.2026038-34","doi-asserted-by":"publisher","unstructured":"Z. J. Hu, J. Xu, J. M. Yin, L. Li, W. Hou, L. L. Zhang, et al., Lower circulating interferon-gamma is a risk factor for lung fibrosis in COVID-19 patients, Front. Immunol.<\/i>, 11<\/b> (2020), 585647. https:\/\/doi.org\/10.3389\/fimmu.2020.585647","DOI":"10.3389\/fimmu.2020.585647"},{"key":"key-10.3934\/mbe.2026038-35","doi-asserted-by":"publisher","unstructured":"J. Liu, S. Li, J. Liu, B. Liang, X. Wang, H. Wang, et al., Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients, EBioMedicine<\/i>, 55<\/b> (2020), 102763. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102763","DOI":"10.1016\/j.ebiom.2020.102763"},{"key":"key-10.3934\/mbe.2026038-36","doi-asserted-by":"publisher","unstructured":"A. C. Gadotti, M. de Castro Deus, J. P. Telles, R. Wind, M. Goes, R. G. C. Ossoski, et al., IFN-$\\gamma$ is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection, Virus Res.<\/i>, 289<\/b> (2020), 198171. https:\/\/doi.org\/10.1016\/j.virusres.2020.198171","DOI":"10.1016\/j.virusres.2020.198171"},{"key":"key-10.3934\/mbe.2026038-37","doi-asserted-by":"publisher","unstructured":"S. Mansoor, A. R. Butt, A. Bibi, S. Mushtaq, I. Ullah, F. Alshahrani, et al., Expression of IFN-Gamma is significantly reduced during severity of COVID-19 infection in hospitalized patients, PLOS ONE<\/i>, 18<\/b> (2023), e0291332. https:\/\/doi.org\/10.1371\/journal.pone.0291332","DOI":"10.1371\/journal.pone.0291332"},{"key":"key-10.3934\/mbe.2026038-38","doi-asserted-by":"publisher","unstructured":"R. Savan, M. Gale, Innate immunity and interferon in SARS-CoV-2 infection outcome, Immunity<\/i>, 56<\/b> (2023), 1443\u20131450. https:\/\/doi.org\/10.1016\/j.immuni.2023.06.018","DOI":"10.1016\/j.immuni.2023.06.018"},{"key":"key-10.3934\/mbe.2026038-39","doi-asserted-by":"publisher","unstructured":"S. M. Schumacher, S. V. Naga Prasad, Tumor necrosis factor-$\\alpha$ in heart failure: An updated review, Curr. cardiol. Rep.<\/i>, 20<\/b> (2018), 117. https:\/\/doi.org\/10.1007\/s11886-018-1067-7","DOI":"10.1007\/s11886-018-1067-7"},{"key":"key-10.3934\/mbe.2026038-40","doi-asserted-by":"publisher","unstructured":"H. Bruunsgaard, K. Andersen-Ranberg, J. v.B Hjelmborg, B. K. Pedersen, B. Jeune, Elevated levels of tumor necrosis factor alpha and mortality in centenarians, Am. J. Med.<\/i>, 115<\/b> (2003), 278\u2013283. https:\/\/doi.org\/10.1016\/s0002-9343(03)00329-2","DOI":"10.1016\/s0002-9343(03)00329-2"},{"key":"key-10.3934\/mbe.2026038-41","doi-asserted-by":"publisher","unstructured":"D. I. Jang, A. H. Lee, H. Y. Shin, H. R. Song, J. H. Park, T. B. Kang, et al., The role of tumor necrosis factor alpha (TNF-$\\alpha$) in autoimmune disease and current TNF-$\\alpha$ inhibitors in therapeutics, Int. J. Mol. Sci.<\/i>, 22<\/b> (2021), 2719. https:\/\/doi.org\/10.3390\/ijms22052719","DOI":"10.3390\/ijms22052719"},{"key":"key-10.3934\/mbe.2026038-42","doi-asserted-by":"publisher","unstructured":"W. H. Mahallawi, O. F. Khabour, Q. Zhang, H. M. Makhdoum. B. A. Suliman, MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile, Cytokine<\/i>, 104<\/b> (2018), 8\u201313. https:\/\/doi.org\/10.1016\/j.cyto.2018.01.025","DOI":"10.1016\/j.cyto.2018.01.025"},{"key":"key-10.3934\/mbe.2026038-43","doi-asserted-by":"publisher","unstructured":"B. Chen, C. Clark, T. Chou, Granulocyte\/macrophage colony-stimulating factor stimulates monocyte and tissue macrophage proliferation and enhances their responsiveness to macrophage colony-stimulating factor, Blood<\/i>, 71<\/b> (1988), 997\u20131002. https:\/\/doi.org\/10.1182\/blood.V71.4.997.997","DOI":"10.1182\/blood.V71.4.997.997"},{"key":"key-10.3934\/mbe.2026038-44","doi-asserted-by":"publisher","unstructured":"Z. M. Zawawi, J. Kalyanasundram, R. M. Zain, R. Thayan, D. F. Basri, W. B. Yap, Prospective roles of tumor necrosis factor-alpha (TNF-$\\alpha$) in COVID-19: Prognosis, therapeutic and management, Int. J. Mol. Sci.<\/i>, 24<\/b> (2023), 6142. https:\/\/doi.org\/10.3390\/ijms24076142","DOI":"10.3390\/ijms24076142"},{"key":"key-10.3934\/mbe.2026038-45","doi-asserted-by":"publisher","unstructured":"Y. Guo, K. Hu, Y. Li, C. Lu, K. Ling, C. Cai, et al., Targeting TNF-$\\alpha$ for COVID\u201319: Recent advanced and controversies, Front. Public Health<\/i>, 10<\/b> (2022), 833967. https:\/\/doi.org\/10.3389\/fpubh.2022.833967","DOI":"10.3389\/fpubh.2022.833967"},{"key":"key-10.3934\/mbe.2026038-46","doi-asserted-by":"publisher","unstructured":"G. Kokkotis, K. Kitsou, I. Xynogalas, V. Spoulou, G. Magiorkinis, I. Trontzas, et al., Systematic review with meta-analysis: COVID-19 outcomes in patients receiving anti-TNF treatments, Aliment. Pharmacol. Ther.<\/i>, 55<\/b> (2022), 154\u2013167. https:\/\/doi.org\/10.1111\/apt.16717","DOI":"10.1111\/apt.16717"},{"key":"key-10.3934\/mbe.2026038-47","doi-asserted-by":"publisher","unstructured":"A. J. Lee, A. A. Ashkar, The dual nature of type \u2160 and type \u2161 interferons, Front. Immunol.<\/i>, 9<\/b> (2018), 2061. https:\/\/doi.org\/10.3389\/fimmu.2018.02061","DOI":"10.3389\/fimmu.2018.02061"},{"key":"key-10.3934\/mbe.2026038-48","doi-asserted-by":"publisher","unstructured":"H. Kelchtermans, A. Billiau, P. Matthys, How interferon-$\\gamma$ keeps autoimmune diseases in check, Trends Immunol.<\/i>, 29<\/b> (2008), 479\u2013486. https:\/\/doi.org\/10.1016\/j.it.2008.07.002","DOI":"10.1016\/j.it.2008.07.002"},{"key":"key-10.3934\/mbe.2026038-49","doi-asserted-by":"publisher","unstructured":"The International Chronic Granulomatous Disease Cooperative Study Group, A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease, N. Engl. J. Med.<\/i>, 324<\/b> (1991), 509\u2013516. https:\/\/doi.org\/10.1056\/NEJM199102213240801","DOI":"10.1056\/NEJM199102213240801"},{"key":"key-10.3934\/mbe.2026038-50","doi-asserted-by":"publisher","unstructured":"A. Elyasi, I. Voloshyna, S. Ahmed, L. J. Kasselman, J. Behbodikhah, J. De Leon, et al., The role of interferon-$\\gamma$ in cardiovascular disease: An update, Inflammation Res.<\/i>, 69<\/b> (2020), 975\u2013988. https:\/\/doi.org\/10.1007\/s00011-020-01382-6","DOI":"10.1007\/s00011-020-01382-6"},{"key":"key-10.3934\/mbe.2026038-51","doi-asserted-by":"publisher","unstructured":"B. Silva, P. A. Krogstad, R. M. Teles, P. R. Andrade, J. Rajfer, M. G. Ferrini, et al., IFN-$\\gamma$-mediated control of SARS-CoV-2 infection through nitric oxide, Front. Immunol.<\/i>, 14<\/b> (2023), 1284148. https:\/\/doi.org\/10.3389\/fimmu.2023.1284148","DOI":"10.3389\/fimmu.2023.1284148"},{"key":"key-10.3934\/mbe.2026038-52","doi-asserted-by":"publisher","unstructured":"R. Karki, B. R. Sharma, S. Tuladhar, E. P. Williams, L. Zalduondo, P. Samir, et al., Synergism of TNF-$\\alpha$ and IFN-$\\gamma$ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes, Cell<\/i>, 184<\/b> (2021), 149\u2013168. https:\/\/doi.org\/10.1016\/j.cell.2020.11.025","DOI":"10.1016\/j.cell.2020.11.025"},{"key":"key-10.3934\/mbe.2026038-53","doi-asserted-by":"publisher","unstructured":"N. Todorovi\u0107-Rakovi\u0107, J. R. Whitfield, Between immunomodulation and immunotolerance: The role of IFN$\\gamma$ in SARS-CoV-2 disease, Cytokine<\/i>, 146<\/b> (2021), 155637. https:\/\/doi.org\/10.1016\/j.cyto.2021.155637","DOI":"10.1016\/j.cyto.2021.155637"},{"key":"key-10.3934\/mbe.2026038-54","doi-asserted-by":"publisher","unstructured":"C. T. Ng, L. Y. Fong, M. N. H. Abdullah, Interferon-gamma (IFN-$\\gamma$): Reviewing its mechanisms and signaling pathways on the regulation of endothelial barrier function, Cytokine<\/i>, 166<\/b> (2023), 156208. https:\/\/doi.org\/10.1016\/j.cyto.2023.156208","DOI":"10.1016\/j.cyto.2023.156208"},{"key":"key-10.3934\/mbe.2026038-55","doi-asserted-by":"publisher","unstructured":"C. van Eeden, L. Khan, M. S. Osman, J. W. C. Tervaert, Natural killer cell dysfunction and its role in COVID-19, Int. J. Mol. Sci.<\/i>, 21<\/b> (2020), 6351. https:\/\/doi.org\/10.3390\/ijms21176351","DOI":"10.3390\/ijms21176351"},{"key":"key-10.3934\/mbe.2026038-56","doi-asserted-by":"publisher","unstructured":"M. H. Abdolvahab, S. Moradi-Kalbolandi, M. Zarei, D. Bose, K. Majidzadeh-A, L. Farahmand, Potential role of interferons in treating COVID-19 patients, Int. Immunopharmacol.<\/i>, 90<\/b> (2021), 107171. https:\/\/doi.org\/10.1016\/j.intimp.2020.107171","DOI":"10.1016\/j.intimp.2020.107171"},{"key":"key-10.3934\/mbe.2026038-57","doi-asserted-by":"publisher","unstructured":"A. J. Sadler, B. R. Williams, Interferon-inducible antiviral effectors, Nat. Rev. Immunol.<\/i>, 8<\/b> (2008), 559\u2013568. https:\/\/doi.org\/10.1038\/nri2314","DOI":"10.1038\/nri2314"},{"key":"key-10.3934\/mbe.2026038-58","doi-asserted-by":"publisher","unstructured":"M. R. Fernando, J. L. Reyes, J. Iannuzzi, G. Leung, D. M. McKay, The pro-inflammatory cytokine, interleukin-6, enhances the polarization of alternatively activated macrophages, PLOS ONE<\/i>, 9<\/b> (2014), e94188. https:\/\/doi.org\/10.1371\/journal.pone.0094188","DOI":"10.1371\/journal.pone.0094188"},{"key":"key-10.3934\/mbe.2026038-59","doi-asserted-by":"publisher","unstructured":"A. Dallagi, J. Girouard, J. Hamelin-Morrissette, R. Dadzie, L. Laurent, C. Vaillancourt, et al., The activating effect of IFN-$\\gamma$ on monocytes\/macrophages is regulated by the LIF\u2013trophoblast\u2013IL-10 axis via Stat1 inhibition and Stat3 activation, Cell. Mol. Immunol.<\/i>, 12<\/b> (2015), 326\u2013341. https:\/\/doi.org\/10.1038\/cmi.2014.50","DOI":"10.1038\/cmi.2014.50"},{"key":"key-10.3934\/mbe.2026038-60","doi-asserted-by":"publisher","unstructured":"P. Chomarat, J. Banchereau, J. Davoust, A. K. Palucka, IL-6 switches the differentiation of monocytes from dendritic cells to macrophages, Nat. Immunol.<\/i>, 1<\/b> (2000), 510\u2013514. https:\/\/doi.org\/10.1038\/82763","DOI":"10.1038\/82763"},{"key":"key-10.3934\/mbe.2026038-61","doi-asserted-by":"publisher","unstructured":"F. Colotta, F. Re, N. Polentarutti, S. Sozzan, A. Mantovani, Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products, Blood<\/i>, 80<\/b> (1992), 2012\u201320. https:\/\/doi.org\/10.1182\/blood.V80.8.2012.2012","DOI":"10.1182\/blood.V80.8.2012.2012"},{"key":"key-10.3934\/mbe.2026038-62","doi-asserted-by":"publisher","unstructured":"B. Drescher, F. Bai, Neutrophil in viral infections, friend or foe, Virus Res.<\/i>, 171<\/b> (2013), 1\u20137. https:\/\/doi.org\/10.1016\/j.virusres.2012.11.002","DOI":"10.1016\/j.virusres.2012.11.002"},{"key":"key-10.3934\/mbe.2026038-63","doi-asserted-by":"publisher","unstructured":"I. E. Galani, E. Andreakos, Neutrophils in viral infections: Current concepts and caveats, J. Leucocyte Biol.<\/i>, 98<\/b> (2015), 557\u2013564. https:\/\/doi.org\/10.1189\/jlb.4VMR1114-555R","DOI":"10.1189\/jlb.4VMR1114-555R"},{"key":"key-10.3934\/mbe.2026038-64","doi-asserted-by":"publisher","unstructured":"S. L. Swain, K. K. McKinstry, T. M. Strutt, Expanding roles for CD4+ T cells in immunity to viruses, Nat. Rev. Immunol.<\/i>, 12<\/b> (2012), 136\u2013148. https:\/\/doi.org\/10.1038\/nri3152","DOI":"10.1038\/nri3152"},{"key":"key-10.3934\/mbe.2026038-65","doi-asserted-by":"publisher","unstructured":"M. Z. Tay, C. M. Poh, L. R\u00e9nia, P. A. MacAry, L. F. Ng, The trinity of COVID-19: Immunity, inflammation and intervention, Nat. Rev. Immunol.<\/i>, 20<\/b> (2020), 363\u2013374. https:\/\/doi.org\/10.1038\/s41577-020-0311-8","DOI":"10.1038\/s41577-020-0311-8"},{"key":"key-10.3934\/mbe.2026038-66","doi-asserted-by":"publisher","unstructured":"A. U. Haq, The effect of IFN-gamma and alpha on CON-A stimulated T-cell proliferation: Role of monocytes, Am. J. Med. Sci.<\/i>, 292<\/b> (1986), 350\u2013355. https:\/\/doi.org\/10.1097\/00000441-198612000-00003","DOI":"10.1097\/00000441-198612000-00003"},{"key":"key-10.3934\/mbe.2026038-67","doi-asserted-by":"publisher","unstructured":"V. J. Costela-Ruiz, R. Illescas-Montes, J. M. Puerta-Puerta, C. Ruiz, L. Melguizo-Rodr\u00edguez, SARS-CoV-2 infection: The role of cytokines in COVID-19 disease, Cytokine Growth Factor Rev.<\/i>, 54<\/b> (2020), 62\u201375. https:\/\/doi.org\/10.1016\/j.cytogfr.2020.06.001","DOI":"10.1016\/j.cytogfr.2020.06.001"},{"key":"key-10.3934\/mbe.2026038-68","doi-asserted-by":"publisher","unstructured":"S. Meidaninikjeh, N. Sabouni, H. Z. Marzouni, S. Bengar, A. Khalili, R. Jafari, Monocytes and macrophages in COVID-19: Friends and foes, Life Sci.<\/i>, 269<\/b> (2021), 119010. https:\/\/doi.org\/10.1016\/j.lfs.2020.119010","DOI":"10.1016\/j.lfs.2020.119010"},{"key":"key-10.3934\/mbe.2026038-69","doi-asserted-by":"publisher","unstructured":"L. Vanderbeke, P. Van Mol, Y. Van Herck, F. De Smet, S. Humblet-Baron, K. Martinod, et al., Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity, Nat. Commun.<\/i>, 12<\/b> (2021), 4117. https:\/\/doi.org\/10.1038\/s41467-021-24360-w","DOI":"10.1038\/s41467-021-24360-w"},{"key":"key-10.3934\/mbe.2026038-70","doi-asserted-by":"publisher","unstructured":"R. Morris, N. J. Kershaw, J. J. Babon, The molecular details of cytokine signaling via the JAK\/STAT pathway, Protein Sci.<\/i>, 27<\/b> (2018), 1984\u20132009. https:\/\/doi.org\/10.1002\/pro.3519","DOI":"10.1002\/pro.3519"},{"key":"key-10.3934\/mbe.2026038-71","unstructured":"C. A. Janeway, P. Travers, M. Walport, M. J. Shlomchik, Immunobiology: The Immune System in Health and Disease<\/i>, Garland Publishing, New York, USA, 2001."},{"key":"key-10.3934\/mbe.2026038-72","doi-asserted-by":"publisher","unstructured":"M. Santill\u00e1n, On the use of the Hill functions in mathematical models of gene regulatory networks, Math. Modell. Nat. Phenom.<\/i>, 3<\/b> (2008), 85\u201397. https:\/\/doi.org\/10.1051\/mmnp:2008056","DOI":"10.1051\/mmnp:2008056"},{"key":"key-10.3934\/mbe.2026038-73","doi-asserted-by":"publisher","unstructured":"U. Nagarajan, Induction and function of IFN$\\beta$ during viral and bacterial infection, Crit. Rev. Immunol.<\/i>, 31<\/b> (2011), 459\u2013474. https:\/\/doi.org\/10.1615\/critrevimmunol.v31.i6.20","DOI":"10.1615\/critrevimmunol.v31.i6.20"},{"key":"key-10.3934\/mbe.2026038-74","doi-asserted-by":"publisher","unstructured":"K. Kl\u00f6ditz, B. Fadeel, Three cell deaths and a funeral: Macrophage clearance of cells undergoing distinct modes of cell death, Cell Death Discovery<\/i>, 5<\/b> (2019), 65. https:\/\/doi.org\/10.1038\/s41420-019-0146-x","DOI":"10.1038\/s41420-019-0146-x"},{"key":"key-10.3934\/mbe.2026038-75","doi-asserted-by":"publisher","unstructured":"S. Elmore, Apoptosis: A review of programmed cell death, Toxicol. Pathol.<\/i>, 35<\/b> (2007), 495\u2013516. https:\/\/doi.org\/10.1080\/01926230701320337","DOI":"10.1080\/01926230701320337"},{"key":"key-10.3934\/mbe.2026038-76","doi-asserted-by":"publisher","unstructured":"P. Chomarat, C. Dantin, L. Bennett, J. Banchereau, A. K. Palucka, TNF skews monocyte differentiation from macrophages to dendritic cells, J. Immunol.<\/i>, 171<\/b> (2003), 2262\u20132269. https:\/\/doi.org\/10.4049\/jimmunol.171.5.2262","DOI":"10.4049\/jimmunol.171.5.2262"},{"key":"key-10.3934\/mbe.2026038-77","doi-asserted-by":"publisher","unstructured":"S. Iwamoto, S. Iwai, K. Tsujiyama, C. Kurahashi, K. Takeshita, M. Naoe, et al., TNF-$\\alpha$ drives human CD14+ monocytes to differentiate into CD70+ dendritic cells evoking Th1 and Th17 responses, J. Immunol.<\/i>, 179<\/b> (2007), 1449\u20131457. https:\/\/doi.org\/10.4049\/jimmunol.179.3.1449","DOI":"10.4049\/jimmunol.179.3.1449"},{"key":"key-10.3934\/mbe.2026038-78","doi-asserted-by":"publisher","unstructured":"A. U. H. Khan, A. K. Ali, B. Marr, D. Jo, S. Ahmadvand, C. Fong-McMaster, et al., The TNF$\\alpha$\/TNFR2 axis mediates natural killer cell proliferation by promoting aerobic glycolysis, Cell. Mol. Immunol.<\/i>, 20<\/b> (2023), 1140\u20131155. https:\/\/doi.org\/10.1038\/s41423-023-01071-4","DOI":"10.1038\/s41423-023-01071-4"},{"key":"key-10.3934\/mbe.2026038-79","doi-asserted-by":"publisher","unstructured":"T. Liu, J. Zhang, Y. Yang, H. Ma, Z. Li, J. Zhang, et al., The role of interleukin-6 in monitoring severe case of coronavirus disease 2019, EMBO Mol. Med.<\/i>, 12<\/b> (2020), e12421. https:\/\/doi.org\/10.15252\/emmm.202012421","DOI":"10.15252\/emmm.202012421"},{"key":"key-10.3934\/mbe.2026038-80","doi-asserted-by":"publisher","unstructured":"A. G. Laing, A. Lorenc, I. Del Molino Del Barrio, A. Das, M. Fish, L. Monin, et al., A dynamic COVID-19 immune signature includes associations with poor prognosis, Nat. Med.<\/i>, 26<\/b> (2020), 1623\u20131635. https:\/\/doi.org\/10.1038\/s41591-020-1038-6","DOI":"10.1038\/s41591-020-1038-6"},{"key":"key-10.3934\/mbe.2026038-81","doi-asserted-by":"publisher","unstructured":"Z. Wang, H. Pan, B. Jiang, Type \u2160 IFN deficiency: An immunological characteristic of severe COVID-19 patients, Signal Transduction Targeted Ther.<\/i>, 5<\/b> (2020), 198. https:\/\/doi.org\/10.1038\/s41392-020-00306-4","DOI":"10.1038\/s41392-020-00306-4"},{"key":"key-10.3934\/mbe.2026038-82","doi-asserted-by":"publisher","unstructured":"D. Acharya, G. Liu, M. U. Gack, Dysregulation of type \u2160 interferon responses in COVID-19, Nat. Rev. Immunol.<\/i>, 20<\/b> (2020), 397\u2013398. https:\/\/doi.org\/10.1038\/s41577-020-0346-x","DOI":"10.1038\/s41577-020-0346-x"},{"key":"key-10.3934\/mbe.2026038-83","doi-asserted-by":"publisher","unstructured":"Y. J. Kang, I. C. Jeung, A. Park, Y. J. Park, H. Jung, T. D. Kim, et al., An increased level of IL-6 suppresses NK cell activity in peritoneal fluid of patients with endometriosis via regulation of SHP-2 expression, Hum. Reprod.<\/i>, 29<\/b> (2014), 2176\u20132189. https:\/\/doi.org\/10.1093\/humrep\/deu172","DOI":"10.1093\/humrep\/deu172"},{"key":"key-10.3934\/mbe.2026038-84","doi-asserted-by":"publisher","unstructured":"M. Craig, A. R. Humphries, M. C. Mackey, A mathematical model of granulopoiesis incorporating the negative feedback dynamics and kinetics of G-CSF\/neutrophil binding and internalization, Bull. Math. Biol.<\/i>, 78<\/b> (2016), 2304\u20132357. https:\/\/doi.org\/10.1007\/s11538-016-0179-8","DOI":"10.1007\/s11538-016-0179-8"},{"key":"key-10.3934\/mbe.2026038-85","doi-asserted-by":"publisher","unstructured":"K. R. Martin, H. L. Wong, V. Witko-Sarsat, I. P. Wicks, G-CSF\u2013a double edge sword in neutrophil mediated immunity, Semin. Immunol.<\/i>, 54<\/b> (2021), 101516. https:\/\/doi.org\/10.1016\/j.smim.2021.101516","DOI":"10.1016\/j.smim.2021.101516"},{"key":"key-10.3934\/mbe.2026038-86","doi-asserted-by":"publisher","unstructured":"B. R\u00f6sler, S. Herold, Lung epithelial GM-CSF improves host defense function and epithelial repair in influenza virus pneumonia\u2014a new therapeutic strategy, Mol. Cell. Pediatr.<\/i>, 3<\/b> (2016), 29. https:\/\/doi.org\/10.1186\/s40348-016-0055-5","DOI":"10.1186\/s40348-016-0055-5"},{"key":"key-10.3934\/mbe.2026038-87","doi-asserted-by":"publisher","unstructured":"J. Scheller, A. Chalaris, D. Schmidt-Arras, S. Rose-John, The pro-and anti-inflammatory properties of the cytokine interleukin-6, Biochim. Biophys. Acta (BBA)-Mol. Cell Res.<\/i>, 1813<\/b> (2011), 878\u2013888. https:\/\/doi.org\/10.1016\/j.bbamcr.2011.01.034","DOI":"10.1016\/j.bbamcr.2011.01.034"},{"key":"key-10.3934\/mbe.2026038-88","doi-asserted-by":"publisher","unstructured":"R. Yang, Q. Zhao, J. Rao, F. Zeng, S. Yuan, M. Ji, et al., SARS-CoV-2 accessory protein ORF7b mediates tumor necrosis factor-$\\alpha$-induced apoptosis in cells, Front. Microbiol.<\/i>, 12<\/b> (2021), 654709. https:\/\/doi.org\/10.3389\/fmicb.2021.654709","DOI":"10.3389\/fmicb.2021.654709"},{"key":"key-10.3934\/mbe.2026038-89","doi-asserted-by":"publisher","unstructured":"Y. Shi, C. H. Liu, A. I. Roberts, J. Das, G. Xu, G. Ren, et al., Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: What we do and don't know, Cell Res.<\/i>, 16<\/b> (2006), 126\u2013133. https:\/\/doi.org\/10.1038\/sj.cr.7310017","DOI":"10.1038\/sj.cr.7310017"},{"key":"key-10.3934\/mbe.2026038-90","doi-asserted-by":"publisher","unstructured":"R. Channappanavar, A. R. Fehr, J. Zheng, C. Wohlford-Lenane, J. E. Abrahante, M. Mack, et al., IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes, J. Clin. Invest.<\/i>, 129<\/b> (2019), 3625\u20133639. https:\/\/doi.org\/10.1172\/JCI126363","DOI":"10.1172\/JCI126363"},{"key":"key-10.3934\/mbe.2026038-91","doi-asserted-by":"publisher","unstructured":"T. Sheahan, A. Sims, S. Leist, A. Sch\u00e4fer, J. Won, A. J. Brown, et al., Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV, Nat. Commun.<\/i>, 11<\/b> (2020), 222. https:\/\/doi.org\/10.1038\/s41467-019-13940-6","DOI":"10.1038\/s41467-019-13940-6"},{"key":"key-10.3934\/mbe.2026038-92","doi-asserted-by":"publisher","unstructured":"Y. Zhao, L. Qin, P. Zhang, K. Li, L. Liang, J. Sun, et al., Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease, JCI Insights<\/i>, 5<\/b> (2020), e139834. https:\/\/doi.org\/10.1172\/jci.insight.139834","DOI":"10.1172\/jci.insight.139834"},{"key":"key-10.3934\/mbe.2026038-93","doi-asserted-by":"publisher","unstructured":"S. Trouillet-Assant, S. Viel, A. Gaymard, S. Pons, J. C. Richard, M. Perret, et al., Type \u2160 IFN immunoprofiling in COVID-19 patients, J. Allergy Clin. Immunol.<\/i>, 146<\/b> (2020), 206\u2013208. https:\/\/doi.org\/10.1016\/j.jaci.2020.04.029","DOI":"10.1016\/j.jaci.2020.04.029"},{"key":"key-10.3934\/mbe.2026038-94","doi-asserted-by":"publisher","unstructured":"K. Yin, M. J. Peluso, X. Luo, R. Thomas, M. G. Shin, J. Neidleman, et al., Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2, Nat. Immunol.<\/i>, 25<\/b> (2024), 218\u2013225. https:\/\/doi.org\/10.1038\/s41590-023-01724-6","DOI":"10.1038\/s41590-023-01724-6"},{"key":"key-10.3934\/mbe.2026038-95","doi-asserted-by":"publisher","unstructured":"A. Goyal, E. F. Cardozo-Ojeda, J. T. Schiffer, Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response, Sci. Adv.<\/i>, 6<\/b> (2020), eabc7112. https:\/\/doi.org\/10.1126\/sciadv.abc7112","DOI":"10.1126\/sciadv.abc7112"},{"key":"key-10.3934\/mbe.2026038-96","doi-asserted-by":"publisher","unstructured":"B. E. Young, S. W. X. Ong, S. Kalimuddin, J. G. Low, S. Y. Tan, J. Loh, et al., Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in singapore, JAMA<\/i>, 323<\/b> (2020), 1488\u20131494. https:\/\/doi.org\/10.1001\/jama.2020.3204","DOI":"10.1001\/jama.2020.3204"},{"key":"key-10.3934\/mbe.2026038-97","doi-asserted-by":"publisher","unstructured":"R. W\u00f6lfel, V. M. Corman, W. Guggemos, M. Seilmaier, S. Zange, M. A. M\u00fcller, et al., Virological assessment of hospitalized patients with COVID-2019, Nature<\/i>, 581<\/b> (2020), 465\u2013469. https:\/\/doi.org\/10.1038\/s41586-020-2196-x","DOI":"10.1038\/s41586-020-2196-x"},{"key":"key-10.3934\/mbe.2026038-98","doi-asserted-by":"publisher","unstructured":"O. J. McElvaney, N. L. McEvoy, O. F. McElvaney, T. P. Carroll, M. P. Murphy, D. M. Dunlea, et al., Characterization of the inflammatory response to severe COVID-19 illness, Am. J. Respir. Crit. Care Med.<\/i>, 202<\/b> (2020), 812\u2013821. https:\/\/doi.org\/10.1164\/rccm.202005-1583OC","DOI":"10.1164\/rccm.202005-1583OC"},{"key":"key-10.3934\/mbe.2026038-99","doi-asserted-by":"publisher","unstructured":"M. Sa Ribero, N. Jouvenet, M. Dreux, S. Nisole, Interplay between SARS-CoV-2 and the type \u2160 interferon response, PLOS Pathog.<\/i>, 16<\/b> (2020), e1008737. https:\/\/doi.org\/10.1371\/journal.ppat.1008737","DOI":"10.1371\/journal.ppat.1008737"},{"key":"key-10.3934\/mbe.2026038-100","doi-asserted-by":"publisher","unstructured":"C. Maucourant, I. Filipovic, A. Ponzetta, S. Aleman, M. Cornillet, L. Hertwig, et al., Natural killer cell immunotypes related to COVID-19 disease severity, Sci. Immunol.<\/i>, 5<\/b> (2020), eabd6832. https:\/\/doi.org\/10.1126\/sciimmunol.abd6832","DOI":"10.1126\/sciimmunol.abd6832"},{"key":"key-10.3934\/mbe.2026038-101","doi-asserted-by":"publisher","unstructured":"E. Andreakos, C. H. G. Effort, Type \u2160 and type \u2162 interferons: From basic biology and genetics to clinical development for COVID-19 and beyond, Semin. Immunol.<\/i>, 72<\/b> (2024), 101863. https:\/\/doi.org\/10.1016\/j.smim.2024.101863","DOI":"10.1016\/j.smim.2024.101863"},{"key":"key-10.3934\/mbe.2026038-102","doi-asserted-by":"publisher","unstructured":"M. M. Islam, S. Islam, R. Ahmed, M. Majumder, B. Sarkar, M. E. R. Himu, et al., Reduced IFN-$\\gamma$ levels along with changes in hematologic and immunologic parameters are key to COVID-19 severity in bangladeshi patients, Exp. Hematol.<\/i>, 118<\/b> (2023), 53\u201364. https:\/\/doi.org\/10.1016\/j.exphem.2022.11.006","DOI":"10.1016\/j.exphem.2022.11.006"},{"key":"key-10.3934\/mbe.2026038-103","doi-asserted-by":"publisher","unstructured":"T. Herold, V. Jurinovic, C. Arnreich, B. J. Lipworth, J. C. Hellmuth, M. von Bergwelt-Baildon, et al., Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19, J. Allergy Clin. Immunol.<\/i>, 146<\/b> (2020), 128\u2013136. https:\/\/doi.org\/10.1016\/j.jaci.2020.05.008","DOI":"10.1016\/j.jaci.2020.05.008"},{"key":"key-10.3934\/mbe.2026038-104","doi-asserted-by":"publisher","unstructured":"W. Hafez, P. Nasa, A. Khairy, M. Jose, M. Abdelshakour, S. Ahmed, et al., Interleukin-6 and the determinants of severe COVID-19: A retrospective cohort study, Medicine<\/i>, 102<\/b> (2023), e36037. https:\/\/doi.org\/10.1097\/MD.0000000000036037","DOI":"10.1097\/MD.0000000000036037"},{"key":"key-10.3934\/mbe.2026038-105","doi-asserted-by":"publisher","unstructured":"Q. X. Long, X. J. Tang, Q. L. Shi, Q. Li, H. J. Deng, J. Yuan, et al., Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections, Nat. Med.<\/i>, 26<\/b> (2020), 1200\u20131204. https:\/\/doi.org\/10.1038\/s41591-020-0965-6","DOI":"10.1038\/s41591-020-0965-6"},{"key":"key-10.3934\/mbe.2026038-106","doi-asserted-by":"publisher","unstructured":"A. Mohamed, S. Zavoshi, R. Mahmood, H. Gidda, The impact of granulocyte colony-stimulating factor administration in a neutropenic cancer patient with COVID-19-related acute respiratory distress syndrome, Cureus<\/i>, 15<\/b> (2023), e35399. https:\/\/doi.org\/10.7759\/cureus.35399","DOI":"10.7759\/cureus.35399"},{"key":"key-10.3934\/mbe.2026038-107","doi-asserted-by":"publisher","unstructured":"A. E. Curtis, T. A. Smith, B. A. Ziganshin, J. A. Elefteriades, The mystery of the Z-score, Aorta<\/i>, 4<\/b> (2016), 124\u2013130. https:\/\/doi.org\/10.12945\/j.aorta.2016.16.014","DOI":"10.12945\/j.aorta.2016.16.014"},{"key":"key-10.3934\/mbe.2026038-108","doi-asserted-by":"publisher","unstructured":"E. Brunet-Ratnasingham, S. Morin, H. Randolph, M. Labrecque, J. B\u00e9lair, R. Lima-Barbosa, et al., Sustained IFN signaling is associated with delayed development of SARS-CoV-2-specific immunity, Nat.Commun.<\/i>, 15<\/b> (2024), 4177. https:\/\/doi.org\/10.1038\/s41467-024-48556-y","DOI":"10.1038\/s41467-024-48556-y"},{"key":"key-10.3934\/mbe.2026038-109","doi-asserted-by":"publisher","unstructured":"S. Sunder, R. Jayaraman, H. S. Mahapatra, S. Sathi, V. Ramanan, P. Kanchi, et al., Estimation of renal function in the intensive care unit: The covert concepts brought to light, J. Intensive Care<\/i>, 2<\/b> (2014), 31. https:\/\/doi.org\/10.1186\/2052-0492-2-31","DOI":"10.1186\/2052-0492-2-31"},{"key":"key-10.3934\/mbe.2026038-110","doi-asserted-by":"publisher","unstructured":"S. Petrov, H. Taskov, M. Murdjeva, Guardians of immunity: NK cell-mediated defense in COVID-19 and post-COVID scenarios, Folia Med.<\/i>, 66<\/b> (2024), 12\u201318. https:\/\/doi.org\/10.3897\/folmed.66.e113356","DOI":"10.3897\/folmed.66.e113356"},{"key":"key-10.3934\/mbe.2026038-111","doi-asserted-by":"publisher","unstructured":"Y. Nishikawa, K. Yamaguchi, M. A. Shofiudin, M. Mimura, M. Takata, S. Mihara, et al., Distinct immunity dynamics of natural killer cells in mild and moderate COVID-19 cases during the Omicron variant phase, Front. Immunol.<\/i>, 16<\/b> (2025), 1594296. https:\/\/doi.org\/10.3389\/fimmu.2025.1594296","DOI":"10.3389\/fimmu.2025.1594296"},{"key":"key-10.3934\/mbe.2026038-112","doi-asserted-by":"publisher","unstructured":"E. O. Gubernatorova, E. A. Gorshkova, A. Polinova, M. Drutskaya, IL-6: Relevance for immunopathology of SARS-CoV-2, Cytokine Growth Factor Rev.<\/i>, 53<\/b> (2020), 13\u201324. https:\/\/doi.org\/10.1016\/j.cytogfr.2020.05.009","DOI":"10.1016\/j.cytogfr.2020.05.009"},{"key":"key-10.3934\/mbe.2026038-113","doi-asserted-by":"publisher","unstructured":"T. Nawar, S. Morjaria, A. Kaltsas, D. Patel, R. Perez-Johnston, A. F. Daniyan, et al., Granulocyte-colony stimulating factor in COVID-19: Is it stimulating more than just the bone marrow, Am. J. Hematol.<\/i>, 95<\/b> (2020), E210. https:\/\/doi.org\/10.1002\/ajh.25870","DOI":"10.1002\/ajh.25870"},{"key":"key-10.3934\/mbe.2026038-114","doi-asserted-by":"publisher","unstructured":"J. F. Bermejo-Martin, R. Almansa, A. P. Tedim, A. de la Fuente, J. M. Eiros, A. Torres, et al., Mounting evidence of impaired viral control in severe COVID-19, Lancet Microbe<\/i>, 2<\/b> (2021), e228\u2013e229. https:\/\/doi.org\/10.1016\/S2666-5247(21)00084-7","DOI":"10.1016\/S2666-5247(21)00084-7"},{"key":"key-10.3934\/mbe.2026038-115","doi-asserted-by":"publisher","unstructured":"J. Yang, L. Zhang, C. Yu, X. F. Yang, H. Wang, Monocyte and macrophage differentiation: Circulation inflammatory monocyte as biomarker for inflammatory diseases, Biomarker Res.<\/i>, 2<\/b> (2014), 1\u20139. https:\/\/doi.org\/10.1186\/2050-7771-2-1","DOI":"10.1186\/2050-7771-2-1"},{"key":"key-10.3934\/mbe.2026038-116","unstructured":"M. M. Dunagan, N. D\u00e1billa, C. McNinch, J. M. Brenchley, P. T. Dolan, J. M. Fox, Activating fc$\\gamma$rs on monocytes are necessary for optimal mayaro virus clearance, bioRxiv<\/i>. https:\/\/doi.org\/10.1101\/2024.07.23.604823<\/ext-link>"},{"key":"key-10.3934\/mbe.2026038-117","doi-asserted-by":"publisher","unstructured":"A. Banete, J. Barilo, R. Whittaker, S. Basta, The activated macrophage\u2013a tough fortress for virus invasion: How viruses strike back, Front. Microbiol.<\/i>, 12<\/b> (2022), 803427. https:\/\/doi.org\/10.3389\/fmicb.2021.803427","DOI":"10.3389\/fmicb.2021.803427"},{"key":"key-10.3934\/mbe.2026038-118","doi-asserted-by":"publisher","unstructured":"J. Li, R. Shan, H. Miller, A. Filatov, M. G. Byazrova, L. Yang, et al., The roles of macrophages and monocytes in COVID-19 severe respiratory syndrome, Cell Insights<\/i>, 2<\/b> (2025), 100250. https:\/\/doi.org\/10.1016\/j.cellin.2025.100250","DOI":"10.1016\/j.cellin.2025.100250"},{"key":"key-10.3934\/mbe.2026038-119","doi-asserted-by":"publisher","unstructured":"M. J. Lee, C. A. Blish, Defining the role of natural killer cells in COVID-19, Nat. Immunol.<\/i>, 24<\/b> (2023), 1628\u20131638. https:\/\/doi.org\/10.1038\/s41590-023-01560-8","DOI":"10.1038\/s41590-023-01560-8"},{"key":"key-10.3934\/mbe.2026038-120","doi-asserted-by":"publisher","unstructured":"J. Majidpoor, K. Mortezaee, Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications, Biomed. Pharmacother.<\/i>, 145<\/b> (2022), 112419. https:\/\/doi.org\/10.1016\/j.biopha.2021.112419","DOI":"10.1016\/j.biopha.2021.112419"},{"key":"key-10.3934\/mbe.2026038-121","doi-asserted-by":"publisher","unstructured":"S. Zhang, B. Asquith, R. Szydlo, J. S. Tregoning, K. M. Pollock, Peripheral T cell lymphopenia in COVID-19: Potential mechanisms and impact, Immunother. Adv.<\/i>, 1<\/b> (2021), ltab015. https:\/\/doi.org\/10.1093\/immadv\/ltab015","DOI":"10.1093\/immadv\/ltab015"},{"key":"key-10.3934\/mbe.2026038-122","doi-asserted-by":"publisher","unstructured":"B. Li, L. L. Jones, T. L. Geiger, IL-6 promotes T cell proliferation and expansion under inflammatory conditions in association with low-level ROR$\\gamma$t expression, J. Immunol.<\/i>, 201<\/b> (2018), 2934\u20132946. https:\/\/doi.org\/10.4049\/jimmunol.1800016","DOI":"10.4049\/jimmunol.1800016"},{"key":"key-10.3934\/mbe.2026038-123","doi-asserted-by":"publisher","unstructured":"L. Velazquez-Salinas, A. Verdugo-Rodriguez, L. L. Rodriguez, M. V. Borca, The role of interleukin 6 during viral infections, Front. Microbiol.<\/i>, 10<\/b> (2019), 1057. https:\/\/doi.org\/10.3389\/fmicb.2019.01057","DOI":"10.3389\/fmicb.2019.01057"},{"key":"key-10.3934\/mbe.2026038-124","doi-asserted-by":"publisher","unstructured":"F. Rollwagen, T. Davis, Y. Y. Li, N. Pacheco, X. L. Zhu, Orally administered IL-6 induces elevated intestinal GM-CSF gene expression and splenic CFU-GM, Cytokine<\/i>, 27<\/b> (2004), 107\u2013112. https:\/\/doi.org\/10.1016\/j.cyto.2004.03.019","DOI":"10.1016\/j.cyto.2004.03.019"},{"key":"key-10.3934\/mbe.2026038-125","doi-asserted-by":"publisher","unstructured":"T. Hartung, Anti-inflammatory effects of granulocyte colony-stimulating factor, Curr. Opin. Hematol.<\/i>, 5<\/b> (1998), 221\u2013225. https:\/\/doi.org\/10.1097\/00062752-199805000-00013","DOI":"10.1097\/00062752-199805000-00013"},{"key":"key-10.3934\/mbe.2026038-126","doi-asserted-by":"publisher","unstructured":"M. Kohanawa, A regulatory effect of the balance between TNF-$\\alpha$ and IL-6 in the granulomatous and inflammatory response to Rhodococcus aurantiacus infection in mice, J. Immunol.<\/i>, 177<\/b> (2006), 642\u2013650. https:\/\/doi.org\/10.4049\/jimmunol.177.1.642","DOI":"10.4049\/jimmunol.177.1.642"},{"key":"key-10.3934\/mbe.2026038-127","doi-asserted-by":"publisher","unstructured":"M. G. Dorrington, I. D. Fraser, NF-$\\kappa$B signaling in macrophages: Dynamics, crosstalk, and signal integration, Front. Immunol.<\/i>, 10<\/b> (2019), 705. https:\/\/doi.org\/10.3389\/fimmu.2019.00705","DOI":"10.3389\/fimmu.2019.00705"},{"key":"key-10.3934\/mbe.2026038-128","doi-asserted-by":"publisher","unstructured":"T. Ota, K. Takeda, H. Akiba, Y. Hayakawa, K. Ogasawara, Y. Ikarashi, et al., IFN-$\\gamma$\u2013mediated negative feedback regulation of NKT-cell function by CD94\/NKG2, Blood<\/i>, 106<\/b> (2005), 184\u2013192. https:\/\/doi.org\/10.1182\/blood-2004-11-4257","DOI":"10.1182\/blood-2004-11-4257"},{"key":"key-10.3934\/mbe.2026038-129","doi-asserted-by":"publisher","unstructured":"S. P. Templeton, S. Perlman, Role of IFN-$\\gamma$ responsiveness in CD8 T cell-mediated viral clearance and demyelination in coronavirus-infected mice, J. Neuroimmunol.<\/i>, 194<\/b> (2008), 18\u201326. https:\/\/doi.org\/10.1016\/j.jneuroim.2007.10.030","DOI":"10.1016\/j.jneuroim.2007.10.030"},{"key":"key-10.3934\/mbe.2026038-130","doi-asserted-by":"publisher","unstructured":"P. Bhat, G. Leggatt, N. Waterhouse, I. H. Frazer, Interferon-$\\gamma$ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity, Cell Death Dis.<\/i>, 8<\/b> (2017), e2836\u2013e2836. https:\/\/doi.org\/10.1038\/cddis.2017.67","DOI":"10.1038\/cddis.2017.67"},{"key":"key-10.3934\/mbe.2026038-131","doi-asserted-by":"publisher","unstructured":"N. Parameswaran, S. Patial, Tumor necrosis factor-$\\alpha$ signaling in macrophages, Crit. Rev. Eukaryotic Gene Expression<\/i>, 20<\/b> (2010), 87\u2013103. https:\/\/doi.org\/10.1615\/critreveukargeneexpr.v20.i2.10","DOI":"10.1615\/critreveukargeneexpr.v20.i2.10"},{"key":"key-10.3934\/mbe.2026038-132","doi-asserted-by":"publisher","unstructured":"T. Cantaert, D. Baeten, P. P. Tak, L. G. van Baarsen, Type \u2160 IFN and TNF$\\alpha$ cross-regulation in immune-mediated inflammatory disease: Basic concepts and clinical relevance, Arthritis Res. Ther.<\/i>, 12<\/b> (2010), 219. https:\/\/doi.org\/10.1186\/ar3150","DOI":"10.1186\/ar3150"},{"key":"key-10.3934\/mbe.2026038-133","doi-asserted-by":"publisher","unstructured":"F. L. van de Veerdonk, E. Giamarellos-Bourboulis, P. Pickkers, L. Derde, H. Leavis, R. van Crevel, et al., A guide to immunotherapy for COVID-19, Nat. Med.<\/i>, 28<\/b> (2022), 39\u201350. https:\/\/doi.org\/10.1038\/s41591-021-01643-9","DOI":"10.1038\/s41591-021-01643-9"},{"key":"key-10.3934\/mbe.2026038-134","doi-asserted-by":"publisher","unstructured":"D. M. Del Valle, S. Kim-Schulze, H. H. Huang, N. D. Beckmann, S. Nirenberg, B. Wang, et al., An inflammatory cytokine signature predicts COVID-19 severity and survival, Nat. Med.<\/i>, 26<\/b> (2020), 1636\u20131643. https:\/\/doi.org\/10.1038\/s41591-020-1051-9","DOI":"10.1038\/s41591-020-1051-9"},{"key":"key-10.3934\/mbe.2026038-135","doi-asserted-by":"publisher","unstructured":"T. Tsao, A. M. Buck, L. Grimbert, B. H. LaFranchi, B. A. Poblano, E. A. Fehrman, et al., Long COVID is associated with lower percentages of mature, cytotoxic nk cell phenotypes, J. Clin. Invest.<\/i>, 135<\/b> (2024). https:\/\/doi.org\/10.1172\/JCI188182","DOI":"10.1172\/JCI188182"},{"key":"key-10.3934\/mbe.2026038-136","doi-asserted-by":"publisher","unstructured":"M. A. Matthay, A. F. Luetkemeyer, IL-6 receptor antagonist therapy for patients hospitalized for COVID-19: Who, when, and how, JAMA<\/i>, 326<\/b> (2021), 483\u2013485. https:\/\/doi.org\/10.1001\/jama.2021.11121","DOI":"10.1001\/jama.2021.11121"},{"key":"key-10.3934\/mbe.2026038-137","doi-asserted-by":"publisher","unstructured":"S. Scherger, A. Henao-Mart\u00ednez, C. Franco-Paredes, L. Shapiro, Rethinking interleukin-6 blockade for treatment of COVID-19, Med. Hypotheses<\/i>, 144<\/b> (2020), 110053. https:\/\/doi.org\/10.1016\/j.mehy.2020.110053","DOI":"10.1016\/j.mehy.2020.110053"},{"key":"key-10.3934\/mbe.2026038-138","doi-asserted-by":"publisher","unstructured":"J. Aguareles, C. Forn\u00e9, A. Garc\u00eda-Casas, G. Santamar\u00eda-Corral, D. Carnevali-Ruiz, G. Sotres-Fern\u00e1ndez, et al., Influence of anti-spike protein antibody levels on tocilizumab efficacy in hospitalized patients with severe COVID-19 pneumonia: A post-hoc analysis of the COVACTA trial, BMC Infect. Dis.<\/i>, 25<\/b> (2025), 1\u20139. https:\/\/doi.org\/10.1186\/s12879-025-11001-6","DOI":"10.1186\/s12879-025-11001-6"},{"key":"key-10.3934\/mbe.2026038-139","doi-asserted-by":"publisher","unstructured":"A. Myasnikov, S. Berns, P. Talyzin, F. Ershov, Interferon gamma in the treatment of patients with moderate COVID-19, Probl. Virol.<\/i>, 66<\/b> (2021), 47\u201354. https:\/\/doi.org\/10.36233\/0507-4088-24","DOI":"10.36233\/0507-4088-24"},{"key":"key-10.3934\/mbe.2026038-140","doi-asserted-by":"publisher","unstructured":"L. S. Nguyen, Z. Ait Hamou, N. Gastli, N. Chapuis, F. P\u00e8ne, Potential role for interferon gamma in the treatment of recurrent ventilator-acquired pneumonia in patients with COVID-19: A hypothesis, Intensive Care Med.<\/i>, 47<\/b> (2021), 619\u2013621. https:\/\/doi.org\/10.1007\/s00134-021-06377-3","DOI":"10.1007\/s00134-021-06377-3"},{"key":"key-10.3934\/mbe.2026038-141","doi-asserted-by":"publisher","unstructured":"A. van Laarhoven, L. Kurver, G. J. Overheul, E. J. Kooistra, W. F. Abdo, R. van Crevel, et al., Interferon gamma immunotherapy in five critically ill COVID-19 patients with impaired cellular immunity: A case series, Med<\/i>, 2<\/b> (2021), 1163\u20131170. https:\/\/doi.org\/10.1016\/j.medj.2021.09.003","DOI":"10.1016\/j.medj.2021.09.003"},{"key":"key-10.3934\/mbe.2026038-142","doi-asserted-by":"publisher","unstructured":"A. Sica, M. Erreni, P. Allavena, C. Porta, Macrophage polarization in pathology, Cell. Mol. Life Sci.<\/i>, 72<\/b> (2015), 4111\u20134126. https:\/\/doi.org\/10.1007\/s00018-015-1995-y","DOI":"10.1007\/s00018-015-1995-y"},{"key":"key-10.3934\/mbe.2026038-143","doi-asserted-by":"publisher","unstructured":"K. S. Kim, K. Ejima, S. Iwanami, Y. Fujita, H. Ohashi, Y. Koizumi, et al., A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2, PLOS Biol.<\/i>, 19<\/b> (2021), e3001128. https:\/\/doi.org\/10.1371\/journal.pbio.3001128","DOI":"10.1371\/journal.pbio.3001128"},{"key":"key-10.3934\/mbe.2026038-144","doi-asserted-by":"publisher","unstructured":"J. D. Crapo, B. E. Barry, P. Gehr, M. Bachofen, E. R. Weibel, Cell number and cell characteristics of the normal human lung, Am. Rev. Respir. Dis.<\/i>, 126<\/b> (1982), 332\u2013337. https:\/\/doi.org\/10.1164\/arrd.1982.126.2.332","DOI":"10.1164\/arrd.1982.126.2.332"},{"key":"key-10.3934\/mbe.2026038-145","doi-asserted-by":"publisher","unstructured":"J. Armstrong, E. Gluck, R. Crapo, H. A. Jones, J. Hughes, Lung tissue volume estimated by simultaneous radiographic and helium dilution methods, Thorax<\/i>, 37<\/b> (1982), 676\u2013679. https:\/\/doi.org\/10.1136\/thx.37.9.676","DOI":"10.1136\/thx.37.9.676"},{"key":"key-10.3934\/mbe.2026038-146","doi-asserted-by":"publisher","unstructured":"N. Chaffey, Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K. and Walter, P. Molecular biology of the cell. 4th edn., Ann. Bot.<\/i>, 91<\/b> (2003), 401\u2013401. https:\/\/doi.org\/10.1093\/aob\/mcg023","DOI":"10.1093\/aob\/mcg023"},{"key":"key-10.3934\/mbe.2026038-147","doi-asserted-by":"publisher","unstructured":"W. Jiang, L. Kang, H. Z. Lu, X. Pan, Q. Lin, Q. Pan, et al., Normal values for CD4 and CD8 lymphocyte subsets in healthy Chinese adults from Shanghai, Clin. Vaccine Immunol.<\/i>, 11<\/b> (2004), 811\u2013813. https:\/\/doi.org\/10.1128\/CDLI.11.4.811-813.2004","DOI":"10.1128\/CDLI.11.4.811-813.2004"},{"key":"key-10.3934\/mbe.2026038-148","doi-asserted-by":"publisher","unstructured":"C. L. Gordon, M. Miron, J. J. Thome, N. Matsuoka, J. Weiner, M. A. Rak, et al., Tissue reservoirs of antiviral T cell immunity in persistent human CMV infection, J. Exp. Med.<\/i>, 214<\/b> (2017), 651\u2013667. https:\/\/doi.org\/10.1084\/jem.20160758","DOI":"10.1084\/jem.20160758"},{"key":"key-10.3934\/mbe.2026038-149","doi-asserted-by":"publisher","unstructured":"F. Bozzano, C. Perrone, L. Moretta, A. De Maria, NK cell precursors in human bone marrow in health and inflammation, Front. Immunol.<\/i>, 10<\/b> (2019), 2045. https:\/\/doi.org\/10.3389\/fimmu.2019.02045","DOI":"10.3389\/fimmu.2019.02045"},{"key":"key-10.3934\/mbe.2026038-150","doi-asserted-by":"publisher","unstructured":"M. Osman, R. M. Faridi, W. Sligl, M. T. Shabani-Rad, P. Dharmani-Khan, A. Parker, et al., Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19, Blood Adv.<\/i>, 4<\/b> (2020), 5035\u20135039. https:\/\/doi.org\/10.1182\/bloodadvances.2020002650","DOI":"10.1182\/bloodadvances.2020002650"},{"key":"key-10.3934\/mbe.2026038-151","doi-asserted-by":"publisher","unstructured":"M. Maes, A. Lin, L. Delmeire, A. Van Gastel, G. Kenis, R. De Jongh, et al., Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events, Biol. Psychiatry<\/i>, 45<\/b> (1999), 833\u2013839. https:\/\/doi.org\/10.1016\/s0006-3223(98)00131-0","DOI":"10.1016\/s0006-3223(98)00131-0"},{"key":"key-10.3934\/mbe.2026038-152","unstructured":"J. Lee, Y. Kim, J. Lim, M. Kim, K. Han, G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia, Ann. Clin. Lab. Sci.<\/i>, 38<\/b> (2008), 331\u2013337."},{"key":"key-10.3934\/mbe.2026038-153","doi-asserted-by":"publisher","unstructured":"K. Suzuki, M. Yamada, S. Kurakake, N. Okamura, K. Yamaya, Q. Liu, et al., Circulating cytokines and hormones with immunosuppressive but neutrophil-priming potentials rise after endurance exercise in humans, Eur. J. Appl. Physiol.<\/i>, 81<\/b> (2000), 281\u2013287. https:\/\/doi.org\/10.1007\/s004210050044","DOI":"10.1007\/s004210050044"},{"key":"key-10.3934\/mbe.2026038-154","doi-asserted-by":"publisher","unstructured":"N. O. Kurtovic, E. K. Halilovic, Serum concentrations of interferon gamma (IFN-$\\gamma$) in patients with psoriasis: Correlation with clinical type and severity of the disease, Med. Arch.<\/i>, 72<\/b> (2018), 410. https:\/\/doi.org\/10.5455\/medarh.2018.72.410-413","DOI":"10.5455\/medarh.2018.72.410-413"},{"key":"key-10.3934\/mbe.2026038-155","doi-asserted-by":"publisher","unstructured":"S. R. Kapadia, K. Yakoob, S. Nader, J. D. Thomas, D. L. Mann, B. P. Griffin, Elevated circulating levels of serum tumor necrosis factor-alpha in patients with hemodynamically significant pressure and volume overload, J. Am. Coll. Cardiol.<\/i>, 36<\/b> (2000), 208\u2013212. https:\/\/doi.org\/10.1016\/s0735-1097(00)00721-x","DOI":"10.1016\/s0735-1097(00)00721-x"},{"key":"key-10.3934\/mbe.2026038-156","doi-asserted-by":"publisher","unstructured":"I. Ioannidis, F. Ye, B. McNally, M. Willette, E. Fla\u00f1o, Toll-like receptor expression and induction of type \u2160 and type \u2162 interferons in primary airway epithelial cells, J. Virol.<\/i>, 87<\/b> (2013), 3261\u20133270. https:\/\/doi.org\/10.1128\/JVI.01956-12","DOI":"10.1128\/JVI.01956-12"},{"key":"key-10.3934\/mbe.2026038-157","doi-asserted-by":"publisher","unstructured":"Y. Jamilloux, T. Henry, A. Belot, S. Viel, M. Fauter, T. El Jammal, et al., Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions, Autoimmun. Rev.<\/i>, 19<\/b> (2020), 102567. https:\/\/doi.org\/10.1016\/j.autrev.2020.102567","DOI":"10.1016\/j.autrev.2020.102567"},{"key":"key-10.3934\/mbe.2026038-158","doi-asserted-by":"publisher","unstructured":"L. M. Carlin, K. Yanagi, A. Verhoef, E. N. N. Hoen, J. Yates, L. Gardner, et al., Secretion of IFN-$\\gamma$ and not IL-2 by anergic human T cells correlates with assembly of an immature immune synapse, Blood<\/i>, 106<\/b> (2005), 3874\u20133879. https:\/\/doi.org\/10.1182\/blood-2005-03-0996","DOI":"10.1182\/blood-2005-03-0996"},{"key":"key-10.3934\/mbe.2026038-159","doi-asserted-by":"publisher","unstructured":"O. Lawal, H. Knobel, H. Weda, L. D. Bos, T. M. Nijsen, R. Goodacre, et al., Volatile organic compound signature from co-culture of lung epithelial cell line with pseudomonas aeruginosa, Analyst<\/i>, 143<\/b> (2018), 3148\u20133155. https:\/\/doi.org\/10.1039\/c8an00759d","DOI":"10.1039\/c8an00759d"},{"key":"key-10.3934\/mbe.2026038-160","doi-asserted-by":"publisher","unstructured":"L. Landsman, S. Jung, Lung macrophages serve as obligatory intermediate between blood monocytes and alveolar macrophages, J. Immunol.<\/i>, 179<\/b> (2007), 3488\u20133494. https:\/\/doi.org\/10.4049\/jimmunol.179.6.3488","DOI":"10.4049\/jimmunol.179.6.3488"},{"key":"key-10.3934\/mbe.2026038-161","doi-asserted-by":"publisher","unstructured":"M. L. Ng, S. H. Tan, E. E. See, E. E. Ooi, A. E. Ling, Proliferative growth of SARS coronavirus in vero E6 cells, J. Gen. Virol.<\/i>, 84<\/b> (2003), 3291\u20133303. https:\/\/doi.org\/10.1099\/vir.0.19505-0","DOI":"10.1099\/vir.0.19505-0"},{"key":"key-10.3934\/mbe.2026038-162","doi-asserted-by":"publisher","unstructured":"A. M. Knaapen, F. Seiler, P. A. Schilderman, P. Nehls, J. Bruch, R. P. Schins, et al., Neutrophils cause oxidative DNA damage in alveolar epithelial cells, Free Radical Biol. Med.<\/i>, 27<\/b> (1999), 234\u2013240. https:\/\/doi.org\/10.1016\/S0891-5849(98)00285-8","DOI":"10.1016\/S0891-5849(98)00285-8"},{"key":"key-10.3934\/mbe.2026038-163","doi-asserted-by":"publisher","unstructured":"C. Nathan, Neutrophils and COVID-19: Nots, nets, and knots, J. Exp. Med.<\/i>, 217<\/b> (2020), e20201439. https:\/\/doi.org\/10.1084\/jem.20201439","DOI":"10.1084\/jem.20201439"},{"key":"key-10.3934\/mbe.2026038-164","doi-asserted-by":"publisher","unstructured":"D. Mathew, J. R. Giles, A. E. Baxter, D. A. Oldridge, A. R. Greenplate, J. E. Wu, et al., Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications, Science<\/i>, 369<\/b> (2020), eabc8511. https:\/\/doi.org\/10.1126\/science.abc8511","DOI":"10.1126\/science.abc8511"},{"key":"key-10.3934\/mbe.2026038-165","doi-asserted-by":"publisher","unstructured":"J. K. Whitmire, J. T. Tan, J. L. Whitton, Interferon-$\\gamma$ acts directly on CD8+ T cells to increase their abundance during virus infection, J. Exp. Med.<\/i>, 201<\/b> (2005), 1053\u20131059. https:\/\/doi.org\/10.1084\/jem.20041463","DOI":"10.1084\/jem.20041463"},{"key":"key-10.3934\/mbe.2026038-166","doi-asserted-by":"publisher","unstructured":"N. Zhang, M. J. Bevan, CD8+ T cells: Foot soldiers of the immune system, Immunity<\/i>, 35<\/b> (2011), 161\u2013168. https:\/\/doi.org\/10.1016\/j.immuni.2011.07.010","DOI":"10.1016\/j.immuni.2011.07.010"},{"key":"key-10.3934\/mbe.2026038-167","doi-asserted-by":"publisher","unstructured":"S. Baral, R. Antia, N. M. Dixit, A dynamical motif comprising the interactions between antigens and CD8 T cells may underlie the outcomes of viral infections, Proc. Natl. Acad. Sci.<\/i>, 116<\/b> (2019), 17393\u201317398. https:\/\/doi.org\/10.1073\/pnas.1902178116","DOI":"10.1073\/pnas.1902178116"},{"key":"key-10.3934\/mbe.2026038-168","doi-asserted-by":"publisher","unstructured":"T. Cassidy, A. R. Humphries, M. Craig, M. C. Mackey, Characterizing chemotherapy-induced neutropenia and monocytopenia through mathematical modelling, Bull. Math. Biol.<\/i>, 82<\/b> (2020), 1\u201326. https:\/\/doi.org\/10.1007\/s11538-020-00777-0","DOI":"10.1007\/s11538-020-00777-0"},{"key":"key-10.3934\/mbe.2026038-169","doi-asserted-by":"publisher","unstructured":"B. Sainz Jr, E. C. Mossel, C. Peters, R. F. Garry, Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV), Virology<\/i>, 329<\/b> (2004), 11\u201317. https:\/\/doi.org\/10.1016\/j.virol.2004.08.011","DOI":"10.1016\/j.virol.2004.08.011"},{"key":"key-10.3934\/mbe.2026038-170","doi-asserted-by":"publisher","unstructured":"L. Sun, J. Rautela, R. B. Delconte, F. Souza-Fonseca-Guimaraes, E. M. Carrington, R. L. Schenk, et al., GM-CSF quantity has a selective effect on granulocytic vs. monocytic myeloid development and function, Front. Immunol.<\/i>, 9<\/b> (2018), 1922. https:\/\/doi.org\/10.3389\/fimmu.2018.01922","DOI":"10.3389\/fimmu.2018.01922"},{"key":"key-10.3934\/mbe.2026038-171","doi-asserted-by":"publisher","unstructured":"M. F. Krummel, J. N. Mahale, L. F. Uhl, E. A. Hardison, A. M. Mujal, J. M. Mazet, et al., Paracrine costimulation of IFN-$\\gamma$ signaling by integrins modulates CD8 T cell differentiation, Proc. Natl. Acad. Sci.<\/i>, 115<\/b> (2018), 11585\u201311590. https:\/\/doi.org\/10.1073\/pnas.1804556115","DOI":"10.1073\/pnas.1804556115"},{"key":"key-10.3934\/mbe.2026038-172","doi-asserted-by":"publisher","unstructured":"M. A. Holsti, J. McArthur, J. P. Allison, D. H. Raulet, Role of IL-6, IL-1, and CD28 signaling in responses of mouse CD4+ T cells to immobilized anti-TCR monoclonal antibody, J. Immunol.<\/i>, 152<\/b> (1994), 1618\u20131628. https:\/\/doi.org\/10.4049\/jimmunol.152.4.1618","DOI":"10.4049\/jimmunol.152.4.1618"},{"key":"key-10.3934\/mbe.2026038-173","doi-asserted-by":"publisher","unstructured":"A. P. Smith, D. J. Moquin, V. Bernhauerova, A. M. Smith, Influenza virus infection model with density dependence supports biphasic viral decay, Front. Microbiol.<\/i>, 9<\/b> (2018), 1554. https:\/\/doi.org\/10.3389\/fmicb.2018.01554","DOI":"10.3389\/fmicb.2018.01554"},{"key":"key-10.3934\/mbe.2026038-174","doi-asserted-by":"publisher","unstructured":"B. Vanherberghen, P. E. Olofsson, E. Forslund, M. Sternberg-Simon, M. A. Khorshidi, S. Pacouret, et al., Classification of human natural killer cells based on migration behavior and cytotoxic response, Blood, J. Am. Soc. Hematol.<\/i>, 121<\/b> (2013), 1326\u20131334. https:\/\/doi.org\/10.1182\/blood-2012-06-439851","DOI":"10.1182\/blood-2012-06-439851"},{"key":"key-10.3934\/mbe.2026038-175","doi-asserted-by":"publisher","unstructured":"M. Ardolino, A. Zingoni, C. Cerboni, F. Cecere, A. Soriani, M. L. Iannitto, et al., DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: Relevance for NK-T cell interaction, Blood, J. Am. Soc. Hematol.<\/i>, 117<\/b> (2011), 4778\u20134786. https:\/\/doi.org\/10.1182\/blood-2010-08-300954","DOI":"10.1182\/blood-2010-08-300954"},{"key":"key-10.3934\/mbe.2026038-176","doi-asserted-by":"publisher","unstructured":"R. C. Rigden, C. P. Carrasco, A. Summerfield, K. C. MCCullough, Macrophage phagocytosis of foot-and-mouth disease virus may create infectious carriers, Immunology<\/i>, 106<\/b> (2002), 537\u2013548. https:\/\/doi.org\/10.1046\/j.1365-2567.2002.01460.x","DOI":"10.1046\/j.1365-2567.2002.01460.x"},{"key":"key-10.3934\/mbe.2026038-177","doi-asserted-by":"publisher","unstructured":"P. Smith, S. Z. Wang, K. Dowling, K. Forsyth, Leucocyte populations in respiratory syncytial virus-induced bronchiolitis, J. Paediatr. Child Health<\/i>, 37<\/b> (2001), 146\u2013151. https:\/\/doi.org\/10.1046\/j.1440-1754.2001.00618.x","DOI":"10.1046\/j.1440-1754.2001.00618.x"},{"key":"key-10.3934\/mbe.2026038-178","doi-asserted-by":"publisher","unstructured":"H. Y. Lee, D. J. Topham, S. Y. Park, J. Hollenbaugh, J. Treanor, T. R. Mosmann, et al., Simulation and prediction of the adaptive immune response to influenza a virus infection, J. Virol.<\/i>, 83<\/b> (2009), 7151\u20137165. https:\/\/doi.org\/10.1128\/JVI.00098-09","DOI":"10.1128\/JVI.00098-09"},{"key":"key-10.3934\/mbe.2026038-179","doi-asserted-by":"publisher","unstructured":"C. S. Zent, M. R. Elliott, Maxed out macs: Physiologic cell clearance as a function of macrophage phagocytic capacity, The FEBS J.<\/i>, 284<\/b> (2017), 1021\u20131039. https:\/\/doi.org\/10.1111\/febs.13961","DOI":"10.1111\/febs.13961"},{"key":"key-10.3934\/mbe.2026038-180","doi-asserted-by":"publisher","unstructured":"E. A. Hernandez-Vargas, J. X. Velasco-Hernandez, In-host mathematical modelling of COVID-19 in humans, Annu. Rev. Control<\/i>, 50<\/b> (2020), 448\u2013456. https:\/\/doi.org\/10.1016\/j.arcontrol.2020.09.006","DOI":"10.1016\/j.arcontrol.2020.09.006"},{"key":"key-10.3934\/mbe.2026038-181","doi-asserted-by":"publisher","unstructured":"F. Ginhoux, M. Guilliams, Tissue-resident macrophage ontogeny and homeostasis, Immunity<\/i>, 44<\/b> (2016), 439\u2013449. https:\/\/doi.org\/10.1016\/j.immuni.2016.02.024","DOI":"10.1016\/j.immuni.2016.02.024"},{"key":"key-10.3934\/mbe.2026038-182","doi-asserted-by":"publisher","unstructured":"R. Eftimie, G. Eftimie, Tumour-associated macrophages and oncolytic virotherapies: A mathematical investigation into a complex dynamics, Lett. Biomath.<\/i>, 5<\/b> (2018), S6\u2013S35. https:\/\/doi.org\/10.1007\/s10238-024-01443-8","DOI":"10.1007\/s10238-024-01443-8"},{"key":"key-10.3934\/mbe.2026038-183","doi-asserted-by":"publisher","unstructured":"A. A. Patel, Y. Zhang, J. N. Fullerton, L. Boelen, A. Rongvaux, A. A. Maini, et al., The fate and lifespan of human monocyte subsets in steady state and systemic inflammation, J. Exp. Med.<\/i>, 214<\/b> (2017), 1913\u20131923. https:\/\/doi.org\/10.1084\/jem.20170355","DOI":"10.1084\/jem.20170355"},{"key":"key-10.3934\/mbe.2026038-184","doi-asserted-by":"publisher","unstructured":"P. S. Kim, P. P. Lee, D. Levy, Modeling regulation mechanisms in the immune system, J. Theor. Biol.<\/i>, 246<\/b> (2007), 33\u201369. https:\/\/doi.org\/10.1016\/j.jtbi.2006.12.012","DOI":"10.1016\/j.jtbi.2006.12.012"},{"key":"key-10.3934\/mbe.2026038-185","doi-asserted-by":"publisher","unstructured":"C. T. Lutz, A. Karapetyan, A. Al-Attar, B. J. Shelton, K. J. Holt, J. H. Tucker, et al., Human NK cells proliferate and die in vivo more rapidly than T cells in healthy young and elderly adults, J. Immunol.<\/i>, 186<\/b> (2011), 4590\u20134598. https:\/\/doi.org\/10.4049\/jimmunol.1002732","DOI":"10.4049\/jimmunol.1002732"},{"key":"key-10.3934\/mbe.2026038-186","doi-asserted-by":"publisher","unstructured":"S. Ye, S. Lowther, J. Stambas, Inhibition of reactive oxygen species production ameliorates inflammation induced by influenza a viruses via upregulation of SOCS1 and SOCS3, J. Virol.<\/i>, 89<\/b> (2015), 2672\u20132683. https:\/\/doi.org\/10.1128\/JVI.03529-14","DOI":"10.1128\/JVI.03529-14"},{"key":"key-10.3934\/mbe.2026038-187","doi-asserted-by":"publisher","unstructured":"Y. Shibata, P. Y. Berclaz, Z. C. Chroneos, M. Yoshida, J. A. Whitsett, B. C. Trapnell, GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU. 1, Immunity<\/i>, 15<\/b> (2001), 557\u2013567. https:\/\/doi.org\/10.1016\/s1074-7613(01)00218-7","DOI":"10.1016\/s1074-7613(01)00218-7"},{"key":"key-10.3934\/mbe.2026038-188","doi-asserted-by":"publisher","unstructured":"M. R. Alderson, T. W. Tough, S. F. Ziegler, K. H. Grabstein, Interleukin 7 induces cytokine secretion and tumoricidal activity by human peripheral blood monocytes, J. Exp. Med.<\/i>, 173<\/b> (1991), 923\u2013930. https:\/\/doi.org\/10.1084\/jem.173.4.923","DOI":"10.1084\/jem.173.4.923"},{"key":"key-10.3934\/mbe.2026038-189","doi-asserted-by":"publisher","unstructured":"M. Hallsworth, C. Soh, S. Lane, J. Arm, T. Lee, Selective enhancement of GM-CSF, TNF-alpha, IL-1 beta and IL-8 production by monocytes and macrophages of asthmatic subjects, Eur. Respir. J.<\/i>, 7<\/b> (1994), 1096\u20131102. https:\/\/doi.org\/10.1183\/09031936.94.07061096","DOI":"10.1183\/09031936.94.07061096"},{"key":"key-10.3934\/mbe.2026038-190","doi-asserted-by":"publisher","unstructured":"M. T. Lee, K. Kaushansky, P. Ralph, M. B. Ladner, Differential expression of M-CSF, G-CSF, and GM-CSF by human monocytes, J. Leukocyte Biol.<\/i>, 47<\/b> (1990), 275\u2013282. https:\/\/doi.org\/10.1002\/jlb.47.3.275","DOI":"10.1002\/jlb.47.3.275"},{"key":"key-10.3934\/mbe.2026038-191","doi-asserted-by":"publisher","unstructured":"M. Ohta, T. Okabe, K. Ozawa, A. Urabe, F. Takaku, 1$\\alpha$, 25-Dihydroxy vitamin D3 (calcitriol) stimulates proliferation of human circulating monocytes in vitro, FEBS Lett.<\/i>, 185<\/b> (1985), 9\u201313. https:\/\/doi.org\/10.1016\/0014-5793(85)80730-4","DOI":"10.1016\/0014-5793(85)80730-4"},{"key":"key-10.3934\/mbe.2026038-192","doi-asserted-by":"publisher","unstructured":"L. R. Krilov, R. M. Hendry, E. Godfrey, K. McIntosh, Respiratory virus infection of peripheral blood monocytes: Correlation with ageing of cells and interferon production in vitro, J. Gen. Virol.<\/i>, 68<\/b> (1987), 1749\u20131753. https:\/\/doi.org\/10.1099\/0022-1317-68-6-1749","DOI":"10.1099\/0022-1317-68-6-1749"},{"key":"key-10.3934\/mbe.2026038-193","doi-asserted-by":"publisher","unstructured":"C. Fauriat, E. O. Long, H. G. Ljunggren, Y. T. Bryceson, Regulation of human NK-cell cytokine and chemokine production by target cell recognition, Blood, J. Am. Soc. Hematol.<\/i>, 115<\/b> (2010), 2167\u20132176. https:\/\/doi.org\/10.1182\/blood-2009-08-238469","DOI":"10.1182\/blood-2009-08-238469"},{"key":"key-10.3934\/mbe.2026038-194","doi-asserted-by":"publisher","unstructured":"H. Aung, Z. Toossi, J. J. Wisnieski, R. S. Wallis, L. A. Culp, N. B. Phillips, et al., Induction of monocyte expression of tumor necrosis factor alpha by the 30-kD alpha antigen of Mycobacterium tuberculosis and synergism with fibronectin, J. Clin. Invest.<\/i>, 98<\/b> (1996), 1261\u20131268. https:\/\/doi.org\/10.1172\/JCI118910","DOI":"10.1172\/JCI118910"},{"key":"key-10.3934\/mbe.2026038-195","doi-asserted-by":"publisher","unstructured":"C. Timmerman, E. Mattsson, L. Martinez-Martinez, L. De Graaf, J. Van Strijp, H. Verbrugh, et al., Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans, Infect. Immun.<\/i>, 61<\/b> (1993), 4167\u20134172. https:\/\/doi.org\/10.1128\/iai.61.10.4167-4172.1993","DOI":"10.1128\/iai.61.10.4167-4172.1993"},{"key":"key-10.3934\/mbe.2026038-196","doi-asserted-by":"publisher","unstructured":"C. M. Freeman, M. K. Han, F. J. Martinez, S. Murray, L. X. Liu, S. W. Chensue, et al., Cytotoxic potential of lung CD8+ T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15, J. Immunol.<\/i>, 184<\/b> (2010), 6504\u20136513. https:\/\/doi.org\/10.4049\/jimmunol.1000006","DOI":"10.4049\/jimmunol.1000006"},{"key":"key-10.3934\/mbe.2026038-197","doi-asserted-by":"publisher","unstructured":"R. Wang, J. J. Jaw, N. C. Stutzman, Z. Zou, P. D. Sun, Natural killer cell-produced IFN-$\\gamma$ and TNF-$\\alpha$ induce target cell cytolysis through up-regulation of ICAM-1, J. Leukocyte Biol.<\/i>, 91<\/b> (2012), 299\u2013309. https:\/\/doi.org\/10.1189\/jlb.0611308","DOI":"10.1189\/jlb.0611308"},{"key":"key-10.3934\/mbe.2026038-198","doi-asserted-by":"publisher","unstructured":"M. Barber\u00e0-Cremades, A. I. G\u00f3mez, A. Baroja-Mazo, L. Mart\u00ednez-Alarc\u00f3n, C. M. Mart\u00ednez, C. de Torre-Minguela, et al., P2X7 receptor induces tumor necrosis factor-$\\alpha$ converting enzyme activation and release to boost TNF-$\\alpha$ production, Front. Immunol.<\/i>, 8<\/b> (2017), 862. https:\/\/doi.org\/10.3389\/fimmu.2017.00862","DOI":"10.3389\/fimmu.2017.00862"},{"key":"key-10.3934\/mbe.2026038-199","doi-asserted-by":"publisher","unstructured":"R. Chentouh, C. Fitting, J. M. Cavaillon, Specific features of human monocytes activation by monophosphoryl lipid A, Sci. Rep.<\/i>, 8<\/b> (2018), 7096. https:\/\/doi.org\/10.1038\/s41598-018-25367-y","DOI":"10.1038\/s41598-018-25367-y"},{"key":"key-10.3934\/mbe.2026038-200","doi-asserted-by":"publisher","unstructured":"M. A. Brehm, K. A. Daniels, R. M. Welsh, Rapid production of TNF-$\\alpha$ following TCR engagement of naive CD8 T cells, J. Immunol.<\/i>, 175<\/b> (2005), 5043\u20135049. https:\/\/doi.org\/10.4049\/jimmunol.175.8.5043","DOI":"10.4049\/jimmunol.175.8.5043"},{"key":"key-10.3934\/mbe.2026038-201","unstructured":"Abcam, Human TNF-$\\alpha$ ELISA kit (Fluorescent) (ab229399), 2026. Available from: https:\/\/www.abcam.com\/en-us\/products\/elisa-kits\/human-tnf-alpha-elisa-kit-fluorescent-ab229399<\/ext-link>."},{"key":"key-10.3934\/mbe.2026038-202","doi-asserted-by":"publisher","unstructured":"R. Mehra, A. Storfer-Isser, H. L. Kirchner, N. Johnson, N. Jenny, R. P. Tracy, et al., Soluble interleukin 6 receptor: A novel marker of moderate to severe sleep-related breathing disorder, Arch. Intern. Med.<\/i>, 166<\/b> (2006), 1725\u20131731. https:\/\/doi.org\/10.1001\/archinte.166.16.1725","DOI":"10.1001\/archinte.166.16.1725"},{"key":"key-10.3934\/mbe.2026038-203","doi-asserted-by":"publisher","unstructured":"J. Stagg, J. H. Wu, N. Bouganim, J. Galipeau, Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy, Cancer Res.<\/i>, 64<\/b> (2004), 8795\u20138799. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-1776","DOI":"10.1158\/0008-5472.CAN-04-1776"},{"key":"key-10.3934\/mbe.2026038-204","doi-asserted-by":"publisher","unstructured":"P. Arnaud, Different interferons: Pharmacology, pharmacokinetics, proposed mechanisms, safety and side effects, La Revue de M\u00e9d. Interne<\/i>, 23<\/b> (2002), 449S\u2013458S. https:\/\/doi.org\/10.1016\/S0248-8663(02)00659-8","DOI":"10.1016\/S0248-8663(02)00659-8"},{"key":"key-10.3934\/mbe.2026038-205","doi-asserted-by":"publisher","unstructured":"Y. Ma, S. Zhao, S. Shen, S. Fang, Z. Ye, Z. Shi, et al., A novel recombinant slow-release TNF $\\alpha$-derived peptide effectively inhibits tumor growth and angiogensis, Sci. Rep.<\/i>, 5<\/b> (2015), 13595. https:\/\/doi.org\/10.1038\/srep13595","DOI":"10.1038\/srep13595"},{"key":"key-10.3934\/mbe.2026038-206","doi-asserted-by":"publisher","unstructured":"J. E. Nesbitt, G. M. Fuller, Dynamics of interleukin-6 internalization and degradation in rat hepatocytes, J. Biol. Chem.<\/i>, 267<\/b> (1992), 5739\u20135742. https:\/\/doi.org\/10.1016\/S0021-9258(18)42613-0","DOI":"10.1016\/S0021-9258(18)42613-0"},{"key":"key-10.3934\/mbe.2026038-207","doi-asserted-by":"publisher","unstructured":"N. A. Nicola, L. Peterson, D. J. Hilton, D. Metcalf, Cellular processing of murine colony-stimulating factor (Multi-CSF, GM-CSF, G-CSF) receptors by normal hemopoietic cells and cell lines, Growth Factors<\/i>, 1<\/b> (1988), 41\u201349. https:\/\/doi.org\/10.3109\/08977198809000245","DOI":"10.3109\/08977198809000245"},{"key":"key-10.3934\/mbe.2026038-208","doi-asserted-by":"publisher","unstructured":"D. E. Mager, W. J. Jusko, Receptor-mediated pharmacokinetic\/pharmacodynamic model of interferon-$\\beta$ 1a in humans, Pharm. Res.<\/i>, 19<\/b> (2002), 1537\u20131543. https:\/\/doi.org\/10.1023\/a:1020468902694","DOI":"10.1023\/a:1020468902694"},{"key":"key-10.3934\/mbe.2026038-209","doi-asserted-by":"publisher","unstructured":"R. Fischer, R. E. Kontermann, K. Pfizenmaier, Selective targeting of TNF receptors as a novel therapeutic approach, Front. Cell Dev. Biol.<\/i>, 8<\/b> (2020), 401. https:\/\/doi.org\/10.3389\/fcell.2020.00401","DOI":"10.3389\/fcell.2020.00401"},{"key":"key-10.3934\/mbe.2026038-210","doi-asserted-by":"publisher","unstructured":"M. Grell, H. Wajant, G. Zimmermann, P. Scheurich, The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor, Proc. Natl. Acad. Sci.<\/i>, 95<\/b> (1998), 570\u2013575. https:\/\/doi.org\/10.1073\/pnas.95.2.570","DOI":"10.1073\/pnas.95.2.570"},{"key":"key-10.3934\/mbe.2026038-211","doi-asserted-by":"publisher","unstructured":"S. Tenhumberg, G. H. Waetzig, A. Chalaris, B. Rabe, D. Seegert, J. Scheller, et al., Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130, J. Biol. Chem.<\/i>, 283<\/b> (2008), 27200\u201327207. https:\/\/doi.org\/10.1074\/jbc.M803694200","DOI":"10.1074\/jbc.M803694200"},{"key":"key-10.3934\/mbe.2026038-212","doi-asserted-by":"publisher","unstructured":"R. Sadir, E. Forest, H. Lortat-Jacob, The heparan sulfate binding sequence of interferon-$\\gamma$ increased the on rate of the interferon-$\\gamma$-interferon-$\\gamma$ receptor complex formation, J. Biol. Chem.<\/i>, 273<\/b> (1998), 10919\u201310925. https:\/\/doi.org\/10.1074\/jbc.273.18.10919","DOI":"10.1074\/jbc.273.18.10919"},{"key":"key-10.3934\/mbe.2026038-213","doi-asserted-by":"publisher","unstructured":"M. Fallahi-Sichani, M. A. Schaller, D. E. Kirschner, S. L. Kunkel, J. J. Linderman, Identification of key processes that control tumor necrosis factor availability in a tuberculosis granuloma, PLOS Comput. Biol.<\/i>, 6<\/b> (2010), e1000778. https:\/\/doi.org\/10.1371\/journal.pcbi.1000778","DOI":"10.1371\/journal.pcbi.1000778"},{"key":"key-10.3934\/mbe.2026038-214","doi-asserted-by":"publisher","unstructured":"L. Snyers, V. Fontaine, J. Content, Modulation of interleukin-6 receptors in human cells, Ann. N. Y. Acad. Sci.<\/i>, 557<\/b> (1989), 388\u2013395. https:\/\/doi.org\/10.1111\/j.1749-6632.1989.tb24031.x","DOI":"10.1111\/j.1749-6632.1989.tb24031.x"},{"key":"key-10.3934\/mbe.2026038-215","doi-asserted-by":"publisher","unstructured":"T. Taga, Y. Kawanishi, R. R. Hardy, T. Hirano, T. Kishimoto, Receptors for B cell stimulatory factor 2. quantitation, specificity, distribution, and regulation of their expression, J. Exp. Med.<\/i>, 166<\/b> (1987), 967\u2013981. https:\/\/doi.org\/10.1084\/jem.166.4.967","DOI":"10.1084\/jem.166.4.967"},{"key":"key-10.3934\/mbe.2026038-216","doi-asserted-by":"publisher","unstructured":"M. Yamaguchi, M. Michishita, K. Hirayoshi, K. Yasukawa, M. Okuma, K. Nagata, Down-regulation of interleukin 6 receptors of mouse myelomonocytic leukemic cells by leukemia inhibitory factor, J. Biol. Chem.<\/i>, 267<\/b> (1992), 22035\u201322042. https:\/\/doi.org\/10.1016\/S0021-9258(18)41631-6","DOI":"10.1016\/S0021-9258(18)41631-6"},{"key":"key-10.3934\/mbe.2026038-217","unstructured":"S. Chiba, A. Tojo, T. Kitamura, A. Urabe, K. Miyazono, F. Takaku, Characterization and molecular features of the cell surface receptor for human granulocyte-macrophage colony-stimulating factor, Leukemia<\/i>, 4<\/b> (1990), 29\u201336."},{"key":"key-10.3934\/mbe.2026038-218","doi-asserted-by":"publisher","unstructured":"D. R. Barreda, P. C. Hanington, M. Belosevic, Regulation of myeloid development and function by colony stimulating factors, Dev. Comp. Immunol.<\/i>, 28<\/b> (2004), 509\u2013554. https:\/\/doi.org\/10.1016\/j.dci.2003.09.010","DOI":"10.1016\/j.dci.2003.09.010"},{"key":"key-10.3934\/mbe.2026038-219","doi-asserted-by":"publisher","unstructured":"A. A. Branca, Interferon receptors, In Vitro Cell. Dev. Biol.<\/i>, 24<\/b> (1988), 155\u2013165. https:\/\/doi.org\/10.1007\/BF02623541","DOI":"10.1007\/BF02623541"},{"key":"key-10.3934\/mbe.2026038-220","doi-asserted-by":"publisher","unstructured":"S. N. Constantinescu, E. Croze, C. Wang, A. Murti, L. Basu, J. E. Mullersman, et al., Role of interferon alpha\/beta receptor chain 1 in the structure and transmembrane signaling of the interferon alpha\/beta receptor complex, Proc. Natl. Acad. Sci.<\/i>, 91<\/b> (1994), 9602\u20139606. https:\/\/doi.org\/10.1073\/pnas.91.20.9602","DOI":"10.1073\/pnas.91.20.9602"},{"key":"key-10.3934\/mbe.2026038-221","doi-asserted-by":"publisher","unstructured":"K. Imamura, D. Spriggs, D. Kufe, Expression of tumor necrosis factor receptors on human monocytes and internalization of receptor bound ligand, J. Immunol.<\/i>, 139<\/b> (1987), 2989\u20132992. https:\/\/doi.org\/10.4049\/jimmunol.139.9.2989","DOI":"10.4049\/jimmunol.139.9.2989"},{"key":"key-10.3934\/mbe.2026038-222","doi-asserted-by":"publisher","unstructured":"E. Pocsik, R. Mihalik, F. Ali-Osman, B. B. Aggarwal, Cell density-dependent regulation of cell surface expression of two types of human tumor necrosis factor receptors and its effect on cellular response, J. Cell. Biochem.<\/i>, 54<\/b> (1994), 453\u2013464. https:\/\/doi.org\/10.1002\/jcb.240540412","DOI":"10.1002\/jcb.240540412"},{"key":"key-10.3934\/mbe.2026038-223","doi-asserted-by":"publisher","unstructured":"S. Kang, T. Tanaka, T. Kishimoto, Therapeutic uses of anti-interleukin-6 receptor antibody, Int. Immunol.<\/i>, 27<\/b> (2015), 21\u201329. https:\/\/doi.org\/10.1093\/intimm\/dxu081","DOI":"10.1093\/intimm\/dxu081"},{"key":"key-10.3934\/mbe.2026038-224","doi-asserted-by":"publisher","unstructured":"T. Hirano, IL-6 in inflammation, autoimmunity and cancer, Int. Immunol.<\/i>, 33<\/b> (2021), 127\u2013148. https:\/\/doi.org\/10.1093\/intimm\/dxaa078","DOI":"10.1093\/intimm\/dxaa078"},{"key":"key-10.3934\/mbe.2026038-225","doi-asserted-by":"publisher","unstructured":"P. J. Murray, The JAK-STAT signaling pathway: Input and output integration, Int. Immunol.<\/i>, 178<\/b> (2007), 2623\u20132629. https:\/\/doi.org\/10.4049\/jimmunol.178.5.2623","DOI":"10.4049\/jimmunol.178.5.2623"},{"key":"key-10.3934\/mbe.2026038-226","doi-asserted-by":"publisher","unstructured":"R. Kurzrock, E. H. Estey, M. Talpaz, J. U. Gutterman, Granulocyte-macrophage colony-stimulating factor in myelodysplastic syndromes and aplastic anemia, Biol. Response Modif. Treat. Hematopoietic Neoplasia<\/i>, 15<\/b> (1992), 173. https:\/\/doi.org\/10.1002\/14651858.CD009310.pub2","DOI":"10.1002\/14651858.CD009310.pub2"},{"key":"key-10.3934\/mbe.2026038-227","unstructured":"MyBioSource, IFN-beta recombinant protein: Interferon-beta 1a Recombinant Protein, 2020. Available from: https:\/\/www.mybiosource.com\/ifn-beta-recombinant-protein\/interferon-beta-1<\/ext-link>."},{"key":"key-10.3934\/mbe.2026038-228","unstructured":"GenScript, TNF-$\\alpha$, Human (Cat. No. Z01001), 2025. Available from: https:\/\/www.genscript.com\/protein\/Z01001-TNF_Human.html<\/ext-link>."},{"key":"key-10.3934\/mbe.2026038-229","unstructured":"M. Rosenblum, N. Donato, Tumor necrosis factor alpha: A multifaceted peptide hormone, Crit. Rev. Immunol.<\/i>, 9<\/b> (1989), 21\u201344."},{"key":"key-10.3934\/mbe.2026038-230","unstructured":"Interferon-$\\gamma$ protein, recombinant human. Available from: https:\/\/www.sigmaaldrich.com\/US\/en\/product\/mm\/if002?emdredirect = 1<\/ext-link>."},{"key":"key-10.3934\/mbe.2026038-231","unstructured":"Useful pharmacokinetic equations, 2013. Available from: https:\/\/pharmacy.ufl.edu\/files\/2013\/01\/5127-28-equations.pdf<\/ext-link>."},{"key":"key-10.3934\/mbe.2026038-232","unstructured":"INTERFERON GAMMA-1B, Available from: https:\/\/drugs.ncats.io\/substance\/21K6M2I7AG<\/ext-link>."},{"key":"key-10.3934\/mbe.2026038-233","doi-asserted-by":"publisher","unstructured":"K. Pallmer, A. Oxenius, Recognition and regulation of T cells by NK cells, Front. Immunol.<\/i>, 7<\/b> (2016), 251. https:\/\/doi.org\/10.3389\/fimmu.2016.00251","DOI":"10.3389\/fimmu.2016.00251"},{"key":"key-10.3934\/mbe.2026038-234","doi-asserted-by":"publisher","unstructured":"L. Cifaldi, G. Prencipe, I. Caiello, C. Bracaglia, F. Locatelli, F. De Benedetti, et al., Inhibition of natural killer cell cytotoxicity by interleukin-6: Implications for the pathogenesis of macrophage activation syndrome, Arthritis rheumatol.<\/i>, 67<\/b> (2015), 3037\u20133046. https:\/\/doi.org\/10.1002\/art.39295","DOI":"10.1002\/art.39295"}],"container-title":["Mathematical Biosciences and Engineering"],"original-title":[],"link":[{"URL":"http:\/\/www.aimspress.com\/article\/doi\/10.3934\/mbe.2026038?viewType=html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T01:39:26Z","timestamp":1772674766000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.aimspress.com\/article\/doi\/10.3934\/mbe.2026038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":234,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3934\/mbe.2026038","relation":{},"ISSN":["1551-0018"],"issn-type":[{"value":"1551-0018","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}